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ABSTRACT 
Teeth form as epithelial appendages such as hairs and glands. During development, 
reciprocal and sequential epithelial-mesenchymal interactions regulate processes 
such as proliferation, differentiation and morphogenesis. These interactions are 
mediated by conserved signaling pathways that are reiteratively used during devel-
opment of all organs. Bone development begins with the formation of mesenchy-
mal condensates. Most bones form through the endochondral ossification mecha-
nism although in the facial area intramembranous ossification predominates. Both 
tooth and bone development is characterized by formation of mineralised tissues, 
which in the tooth include bone-like dentin and cementum as well as epithelially 
derived enamel. 
Mutations in genes encoding molecules in the signaling pathways cause numer-
ous abnormalities in craniofacial bones and teeth including missing or supernumer-
ary teeth, and disturbances in formation of dentin and enamel. Cleidocranial dys-
plasia (CCD) is a congenital syndrome where both bone and tooth development is 
affected. The syndrome is characterized by short stature, missing or abnormal 
clavicles, general bone dysplasia, tooth eruption problems, and supernumerary 
teeth. CCD is caused by mutations in RUNX2, a transcription factor that is a key 
regulator of osteoblast differentiation and bone formation 
The first aim of this study was to analyse the expression of a family of key sig-
naling molecule Bone morphogenetic protein (Bmp) at different stages of tooth 
development. Bmps have a variety of functions and they were originally discovered 
as signals inducing ectopic bone formation. We performed a comparative in situ
hybridisation analysis of the mRNA expression of Bmp2, -3, -4, -5, -6, and -7 from 
initiation of tooth development to differentiation and crown formation. Bmp2, -4,
and -7 were frequently coexpressed and showed marked associations with epithe-
lial-mesenchymal interactions. Their expression shifted between the epithelium and 
mesenchyme starting from the stage of tooth initiation and they were subsequently 
expressed in the enamel knot, the signaling center regulating morphogenesis. In 
addition, their expression domains prior to and during the differentiation of odon-
toblasts and ameloblasts were in line with functions in cell differentiation and/or 
secretory activities of the cells. The expression of Bmp3 was confined to mesen-
chymal cells, in particular to the dental follicle cells that give rise to the cemento-
blasts. Bmp5 was expressed only in the epithelial ameloblasts. Bmp5 may be in-
volved in the induction and formation of dentine and enamel, and Bmp3 in the 
development of cementum, respectively. The remarkable overlaps in the expression 
domains of different Bmp genes may implicate functional redundancy and/or for-
mation of active heterodimers between different Bmps. 
The second aim was to study the role of Runx2 during tooth development and 
thereby to gain better understanding of the pathogenesis of the tooth phenotype in 
CCD. To elucidate Runx2 function we analysed the tooth phenotype of Runx2
knockout mice. Molars of both wild-type and Runx2 mutant mice were analysed 
using several methods including in situ hybridisation, tissue culture, bead implanta-
tion experiments, and epithelial-mesenchymal recombination studies. In situ hy-
bridisation analysis of Runx2 expression showed that it is restricted to dental mes-
enchyme between the bud and early bell stages of tooth development. Although 
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Runx2 regulates osteoblast differentiation, it was downregulated in fully differenti-
ated odontoblasts. However, it was expressed in ameloblasts during the maturation 
phase of enamel formation. Epithelial-mesenchymal recombinants demonstrated 
that the dental epithelium regulates mesenchymal Runx2 expression during the bud 
and cap stages. This effect could be mimicked by Fgf but not by Bmp in bead im-
plantation assays. 
Phenotypic analysis of Runx2 -/- mutant tooth development showed that teeth 
failed to advance beyond the bud stage and that mandibular molars were more se-
verely affected than maxillary molars. Runx2 -/- tooth explants, when transplanted 
beneath the kidney capsules of nude mice, failed to progress in development. Tooth 
epithelial-mesenchymal recombinations using wild-type and Runx2 mutant tissues 
indicated that the defect in the mesenchyme cannot be rescued by normal dental 
epithelium.  
We searched for downstream targets of Runx2 by extensive in situ hybridisation 
analysis. The expression of Fgf3 was downregulated in the mesenchyme of Runx2 -
/- teeth. FGF-soaked beads failed to induce Fgf3 expression in Runx2 -/- dental 
mesenchyme whereas in wild-type mesenchyme they induced Fgf3 in all explants. 
Fgf3 was induced by overexpression of Runx2 in cultured Runx2 -/- calvarial cells 
suggesting that Fgf3 may be a direct target of Runx2. Furthermore, Runx2 was 
downregulated in Msx1 -/- tooth germs indicating that Runx2 functions down-
stream of Msx1 in the dental mesenchyme. Shh expression was absent from the 
enamel knot in the lower molars of Runx2 -/- and reduced in the upper molars. 
However, neither FGF or Shh could rescue the expression of Shh in the enamel 
knot nor morphogenesis of the Runx2 -/- molars. Other enamel knot markers were 
expressed normally in mutant upper molars, while reduced or missing in lower 
molars.  
In conclusion, these studies showed that Runx2 regulates key epithelial-
mesenchymal interactions that control advancing tooth morphogenesis and histo-
differentiation of the epithelial enamel organ, and that it mediates the functions of 
epithelial Fgf signals regulating the expression of mesenchymal Fgf3 which may 
be a direct target gene of Runx2. These data indicate a non-redundant role for 
Runx2 in tooth development that may be distinct from its role in bone formation. In 
addition, in the upper molars of Runx2 mutants extra buddings occurred at the pala-
tal side of the tooth bud which provided clues for the pathogenesis of CCD. We 
suggest that these extra buds occur at sites where the formation of the secondary 
teeth is normally prevented in mice and that Runx2 acts as an inhibitor of succes-
sional tooth formation by preventing advancing development of the buds. Accord-
ingly, we propose that RUNX2 haploinsufficiency in humans cause incomplete 
inhibition of successional tooth formation resulting in supernumerary teeth. 
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REVIEW OF THE LITERATURE 
Regulation of embryonic development 
Embryonic development is regulated by the genetic code and epigenetic interac-
tion. The development of an organism is accomplished mainly by proliferation, 
differentiation, patterning and morphogenesis. Embryonic development begins 
with a single cell, the fertilized egg, which divides mitotically to produce a multi-
cellular organism in which each cell contains the same DNA. During development 
growth can be accomplished by proliferation, or increase of cell size or by extracel-
lular matrix. Cells that have undergone proliferation usually continue to either pro-
liferate or differentiate. Differentiation results from the expression of specific set of 
genes according to the type of cells. Patterning is providing the blueprint of the 
organism, defining where each tissue and organ should be in the three dimensional 
space. Morphogenesis regulates the modeling of each tissue and organ to produce 
the shape and function needed. Patterning and morphogenesis are closely linked 
processes and by morphogenesis the organism is patterned. During gastrulation of 
the embryo, three germ layers are produced, endoderm, mesoderm and ectoderm. 
Endoderm gives rise to the lining of the digestive tube and respiratory system. 
From mesoderm form the bones, muscle, heart, blood cells, kidneys and gonads. 
Ectoderm gives rise to epidermis, nervous system, pigment cells and, in teeth, the 
enamel producing ameloblasts. Signals and signaling pathways that regulate 
morphogenesis have been conserved between different organs, and even between 
invertebrates and vertebrates (reviewed by Gilbert, 2006). 
Congenital anomalies can be caused by genetic or environmental factors. Syn-
dromes consist of sets of developmental abnormalities that are linked to each other. 
Organs that are linked in developmental syndromes share either a common origin 
or a common mechanism of formation. In recent years, the molecular etiology of 
several craniofacial developmental syndromes have been described, including 
CCD, hemifacial microsomia, Treacher Collins syndrome and many more. In addi-
tion, many mutations are known which cause dental abnormalities such as congeni-
tally missing teeth, supernumerary teeth, and dentin and enamel formation distur-
bances. By finding the causative gene mutation in a developmental syndrome, the 
understanding of molecular pathogenesis can be further studied and eventually lead 
to a more complete etiological picture and thus targeted and more effective treat-
ment (reviewed by Rice, 2005). 
Cell and tissue interactions
Inductive interactions involve an inducer that signals to a responding tissue, which, 
if competent, responds to the signal (Fig. 1). Throughout development, reciprocal 
and sequential inductive interactions take place between tissues. This mechanism 
ensures that the adjacent tissues are compatible with each other and that the timing 
is controlled. Cascades of inductive events are responsible for organ development. 
Most organs are formed of epithelial and mesenchymal tissues and interactions 
between these tissue layers regulate proliferation, differentiation and morphogene-
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sis and are transduced by signaling molecules. Depending on developmental stage 
and organ system, either epithelium or mesenchyme may play an instructive role in 
organogenesis. In many organs the mesenchyme is the dominant tissue in early 
stages but later this capacity shifts to the epithelium by the epithelial-mesenchyme 
interactions.
Signal transduction 
Paracrine factors
Extracellular matrix
B C DA
Fig. 1. Inductive interactions are transmitted through either juxtacrine or paracrine mecha-
nisms. Juxtacrine interactions take place between the cell membranes of adjacent cells or 
between a cell membrane and an extracellular matrix secreted by another cell (A, B). 
Paracrine interactions occur when a cell or tissue secretes soluble proteins that induce 
changes in neighbouring cells (C, D). Paracrine factors are proteins secreted by inducing 
cells that bind to cell membrane receptors in competent responding cells. In addition, some 
paracrine factors are thought to act as morphogens, which can diffuse over several cell 
layers, form concentration gradients and thus, specify distinct cell fates. Competent cells 
respond to paracrine factors through signal transduction pathways. Signal transduction 
pathways begin with a paracrine or juxtacrine factor (signaling molecule) binding to cell 
membrane receptor which leads to activation of the cytoplasmic domain of the receptor 
protein. This activity allows the receptor to phosphorylate other cytoplasmic proteins. 
Eventually, a cascade of such reactions activates a transcription factor (or set of factors) 
that activates or represses specific gene activity (reviewed by Gilbert, 2006). 
Transcription factors 
There is cross talk between signal transduction pathways, which allows the cell to 
respond to multiple inputs simultaneously. The maintenance of the differentiated 
state can be accomplished by positive feedback loops involving transcription fac-
tors, or signaling molecules. Transcription factors are proteins that bind to enhan-
 12
cer or promoter regions and interact to activate or repress the transcription of a 
particular gene. Transcription factors have three major domains. The first is a 
DNA-binding domain that recognizes a particular DNA sequence. The second is a 
trans-activating domain that activates or suppresses the transcription of the target 
gene to whose promoter or enhancer the factor has bound. The third is a protein-
protein interaction domain that allows the transcription factor’s activity to be 
modulated by other transcription factors. 
Transcription factors can be grouped together in families based on similarities 
in structure and DNA-binding sites (reviewed by Gilbert, 2006). Such transcription 
factor families include Homeobox (including Msx, Dlx, Otlx, Hox), basic-helix-
loop-helix, Runx, Pax, Fox, Basic leucine zipper, Zinc finger, Nuclear hormone 
receptors and Sry-Sox families. 
Families of signal molecules
Structure and function of signaling molecule families involved in this study will be 
described in following section. Some details about possible functions during em-
bryonic development are also mentioned. Involvement in tooth and bone develop-
ment will also be briefly described. The stages of tooth development is described in 
Fig. 5 (page 25) and 6 (page 29). Tooth and bone development, including molecu-
lar regulation, is described in detail in a later section (pages 20-32). 
 Tgf? superfamily 
Structure and function 
The Tgf? superfamily consists of more than 50 structurally related members with 
several subgroups including Tgf?s, Bmps and Activin/Inhibin. Most of the mole-
cules are signaling factors and their inhibitors (Massague, 2000; Balemans and Van 
Hul., 2002). As in many other signal transduction pathways the expression of both 
the signal, it’s inhibitor and the receptor is under intrinsic control. In the Tgf? su-
perfamily the signal transduction is fairly well known and studied. Members of the 
Tgf? superfamily are synthesized as large precursor molecules that are proteolyti-
cally cleaved to yield biologically active dimers. Homodimer is the most common 
form but some members, e.g., Activins and Bmps, can also form heterodimers (Ho-
gan,1996).  
The activated type I receptor propagates the signal downstream through the 
phosphorylation of the cytoplasmic Smad family transcription factors (R-smads, 
receptor regulated). R-smads form heteromeric complexes with Smad4 (common 
partner Smad, co-smad) mediating the signal into the nucleus for the activation of 
target genes (Peik et al., 1999; Massague and Wotton, 2000; Balemans et al., 
2002). Tgf? and Activin signals are mediated by R-smads Smad 2 and Smad 3, and 
Bmp signals by Smad1, -5 and -8, respectively (Fig. 2). 
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Fig. 2. Schematic presentation of the Tgf? superfamily signal transduction. Tgf?1-3, 
Bmp2-7 and Activin all bind to similar receptor complexes. The receptor complex consists 
of two transmembrane type I receptors (also know as Activin like receptor-like kinase, Alk) 
and two type II receptors with serine-threonine kinase activity (Piek et., 1999). Several 
different isoforms of type I and type II receptors exist and their affinity for the different 
signaling molecules in the Tgf? family varies. Tgf? binds to the Tgf?rII type II receptor, 
and Activin to the type II receptors Actr-IIA and –IIB. Bmp2/4 bind to the type II receptor 
Bmpr-II. Bmp7 binds both to the Bmpr-II and Actr-IIA and –IIB. Of the type I receptors 
Tgf? binds to Alk5, Activin to Alk2, and -4, Bmp7 to Alk2, -4, and -6 and Bmp2/4 to Alk3 
and -6. Upon ligand binding a ligand-receptor complex is formed and the type II receptor 
activates type I receptor by phosphorylation.
Regulation of the signal transduction is delicately controlled by inhibitory signals 
on all levels in the pathway. In the Bmp signaling pathway, inhibition take place 
intracellularly by inhibitory Smads (I-Smads; Smad6 and -7). Smad6 appears to 
inhibit Bmp signaling by binding to the Smad1, and Smad7 inhibits Tgf? signaling 
by binding to Smad2 and -3 and thus interfering with the complex formation with 
Smad4 (reviewed by Tsumaki and Yoshikawa, 2005). In addition, Smurfs inhibit 
Bmp and Tgf? signaling intracellularly, by degrading Smads1 and -5 and by inter-
acting with Smads6 and -7 to degrade Bmp and Tgf? type I receptors (Tsumaki and 
Yoshikawa, 2005). Inhibition can also take place at the plasma membrane level by 
pseudoreceptor Bambi. At the extracellular level several modulators of the Bmp 
signaling is known including Noggin, Chordin, Chordin-like, Dan/Cerberus protein 
family, Sclerostin, Ectodin, Follistatin and Follistatin-related proteins (Balemans 
and Van Hul, 2002; Laurikkala et al., 2003). In addition, Bmp3 has been shown to 
inhibit Bmp signaling (Daluiski et al., 2001; Gamer et al., 2005). Bmp/Tgf? signal-
ing can also be transduced intracellularly by MAP kinase signaling pathways JNK, 
p38 and Erk that does not involve Smads (Derynck et al., 2003). 
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Tgf? superfamily during embryonic development 
Members of the Tgf? superfamily play diverse roles during embryogenesis, includ-
ing morphogenesis and angiogenesis, and in the regulation of homeostasis in adult 
tissues. A wide spectrum of cellular functions during embryogenesis such as prolif-
eration, apoptosis, differentiation, and migration are controlled by Tgf?s (Peik et 
al., 1999; Massague, 2000; Balemans et al., 2002). The role of Tgf?1-3, Bmp2-7, 
Activin and Follistatin are probably best known and will be addressed in more 
detail as examples of function of the superfamily members. 
Tgf?1-3
Three isoforms of Tgf? are known which have unique expression patterns, e.g. 
Tgf?1-3 (Pelton et al., 1991). Tgf?1-3 are involved in proliferation and differentia-
tion of osteoblasts, osteoclasts and chondroblasts (reviewed by Karsenty, 1998). 
Tgf?1 expression was the first to be shown to shift between epithelium and mesen-
chyme and to be associated with known inductive tissue interactions. In tooth de-
velopment at bud stage, Tgf?1 is expressed in the epithelium and then shifts to the 
condensing mesenchyme. During cap stage it is expressed intensely in the cervical 
loop epithelium (Vaahtokari et al., 1991). Tgf?1-3 are expressed intensely during 
odontoblast and ameloblast differentiation (Pelton et al., 1990; Vaahtokari et al., 
1991). Tissue recombination experiments showed that epithelial Tgf?1 is in-
duced/maintained by mesenchymal signals during tooth development (Vaahtokari 
et al., 1991). Tgf?2 deficient mice exhibit a wide variety of defects including a 
small dysmorphic mandible, cleft palate and a reduction in cranial bone size and 
ossification (Sanford et al., 1997). Tgf?3 knockout mice have cleft palate (Proetzel 
et al., 1995). A role for Tgf? in suture development has also been demonstrated. 
Tgf?1 and -2 are associated with rat suture development and continue to be ex-
pressed later during suture closure while Tgf?3 has a role in keeping calvarial su-
tures patent (Opperman et al., 1997; Roth et al., 1997, Lin et al., 1997).
Bmp2-7 
Bmps were found by their ability to induce ectopic bone and cartilage formation, 
and hence named bone morphogenetic proteins (Urist, 1965; Wozney et al., 1988). 
Bmps can initiate ectopic bone formation and they have been suggested to be of 
key importance during mesenchymal condensation (reviewed by Li and Cao, 
2006). Bmps have been shown to have functions in chondrocyte and osteoblast 
differentiation mediated through induction of Msx genes (reviewed by Li and Cao, 
2006). Bmps are expressed in the condensed mesenchyme of bone primordia and in 
the perichondrium and periosteum (Bmp2, -4, -5 and -7; Lyons et al., 1989; 
Kingsley, 1994), as well as in osteoblasts and hypertrophic cartilage (Bmp6; Gitel-
man et al., 1994, 1995). Bmp5 inactivation causes the mouse mutation short ear, 
which is characterized by several skeletal defects (Kingsley, 1992). Apart from 
skeletal development, Bmps have also pleiotropic roles in the induction of ventral 
mesoderm, differentiation of neural tissues, and in controlling multiple organoge-
netic processes (reviewed by Hogan, 1996). Bmp signals have been shown to have 
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a wide range of biological activities and regulating cell growth, proliferation, dif-
ferentiation, chemotaxis and apoptosis in various cell types. Several knockouts of 
Bmps have been made to elucidate their function during embryogenesis. Bmp2/4
knockout mice are early embryonic lethal (Winnier et al., 1995; Zhang and Brad-
ley, 1996). Bmp3 knockout mice exhibit increased bone density (Daluiski et al., 
2001). Bmp6 null mutant mice have delayed sternum ossification (Solloway et al., 
1998). Bmp7 knockout mouse revealed that apart from few skeletal deformities 
several other defects were found including those in kidneys and eyes (Dudley et al., 
1995; Luo et al., 1995, reviewed by Karsenty, 1998). Bmp2 has been shown to 
possess functions during heart development and Bmp4 in the development of lungs 
and testis (reviewed by Karsenty, 1998). Bmp4 and 7 are involved in the patterning 
of the neural tube (reviewed by Hogan, 1996). Bmp2, -4, and -7 are parts of the 
signaling networks that regulate patterning and outgrowth in the developing limbs 
(Francis et al, 1994). In the developing hair follicle Bmp7 is expressed in the 
epithelial placode whereas Bmp4 is expressed in the mesenchymal condensation 
beneath the placode (Chuong 1998; Millar 2002).  
Bmps in tooth development 
The expression of several Bmps has been localized to the developing tooth at sev-
eral stages (Vainio et al., 1993; reviewed by Thesleff and Mikkola, 2002). Of par-
ticular interest was the observation that Bmp4 is associated with the shift of odon-
togenic potential from epithelium to mesenchyme (Vainio et al., 1993). Bmps have 
been shown to participate in epithelial mesenchymal signaling regulating tooth 
morphogenesis (Thesleff et al., 1995). Bmp2, -4,and -7 were localized in a re-
stricted epithelial cell population, the enamel knot together with other signaling 
molecules suggesting functions as signals regulating the shape of teeth (Jernvall et 
al., 1994; Vaahtokari et al., 1996; Jernvall et al., 1998). Several Bmps have been 
localized in odontoblasts and ameloblasts (Lianja et al., 1993; Begue-Kirn et al., 
1994).  
Activin and Follistatin 
Activins regulate growth and differentiation in many biological systems, including 
mesoderm induction, development of reproductive system, erythropoesis, neural 
cell differentiation and bone remodelling (Thomsen et al., 1990, Woodruff, 1998; 
Maeshima et al., 2001; Chang et al., 2001; Lin et al., 2003). Activin ?A is expressed 
in the dental mesenchyme since the initiation of tooth development. At bell stage, 
intense Activin transcripts are restricted to the cusp region of dental papilla mesen-
chyme (Heikinheimo et al., 1997; Ferguson et al., 1998). Activin ?A null mutant 
mice die soon after birth with defects in whiskers, hard palate and teeth (Matzuk et 
al., 1995). Activin ?A null mutant mandibular molars and incisors are arrested at the 
bud stage, but maxillary molars are unaffected (Ferguson et al., 1998). Activin acts 
on the dental epithelium and reciprocally induces the expression of its own inhibi-
tor Follistatin (Ferguson et al., 1998) 
Follistatin is an extracellular inhibitor of several members of the Tgf? super-
family proteins, including Activin, Bmp2, -4, and -7 (reviewed by Li and Cao, 
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2006; reviewed by Rosen, 2006). It has been shown that Follistatin regulates tooth 
morphogenesis and tooth crown shape (Wang et al., 2004). Furthermore, Follistatin 
regulates enamel patterning in mouse incisors by asymmetrically inhibiting Bmp 
signaling and thus ameloblast differentiation (Wang et al., 2004). 
Fgf family 
Structure and function 
Fgfs form a growth factor family of intercellular signaling molecules which in ver-
tebrates consists of 22 members (Ornitz and Itoh, 2001). Fgfs are major regulators 
of embryonic development and affect a variety of cellular functions such as prolif-
eration, survival, differentiation, adhesion and migration (Szebenyi and Fallon, 
1999). Fgfs bind to cell surface receptors which are single transmembrane proteins 
with intracellular tyrosine kinase domains. Their extracellular domain consists of 
immunoglobulin-like motifs one of which (the Ig-3 loop) determines the ligand 
selectivity. There are four Fgf receptor genes in vertebrates, but in dental tissues 
only three Fgfr are expressed (Fgfr1, -2, and -3). Alternative splicing creates recep-
tors with two different Ig-3 loops and hence Fgfr1, -2, and -3 exist in two isoforms 
with differences in ligand binding. The extracellular domain of Fgf receptors inter-
acts with heparan sulphate proteoglycans (HSPG), including syndecan and perle-
can, which regulates ligand binding (Zhu et al., 1991; Faham et al., 1996; Ornitz 
2000; Ornitz and Itoh 2001). When a Fgf-cofactor complex binds to an Fgfr, the 
receptor either homo- or heterodimerizes, which in turn leads to phosphorylation 
and intracellular signal transduction (Givol and Yayon, 1992; Johnson and Wil-
liams, 1993; Faham et al., 1996). Numerous indirect and direct Fgf-regulated target 
genes have been identified including Sprouty genes encoding inhibitors of Fgf sig-
naling (Casci et al., 1999; Mailleux et al., 2001). 
Fgfs during embryonic development 
Most if not all Fgfs are required throughout embryonic development for the 
morphogenesis of various organs and tissues. Fgfs3, -4 and -5 are involved in early 
development both prior to and during gastrulation and neurulation (Wilkinson et 
al., 1988; Haub and Goldfarb, 1991; Niswander and Martin, 1992; Slack, 1994, 
reviewed by Crossley and Martin, 1995). Fgfs1, -2, -3, -4, -8, and -9 are involved 
in limb bud development (reviewed by Martin, 1998) and Fgf8 is involved in brain 
development (Crossley et al., 1996). In the lung, the Fgf family member, Fgf10 has 
the potential to induce bud formation and thus it stimulates branching morphogene-
sis (Bellusci et al., 1997). The role of Fgfs has also been analyzed extensively in 
the morphogenesis of a variety of organs developing as epithelial appendages such 
as hairs, glands and teeth (Chuong, 1998; Kettunen and Thesleff, 1998; Kettunen et 
al., 2000; Mailleux et al., 2001).
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Hedgehog family 
Structure and function 
Hedgehog (Hh) gene was discovered originally in Drosophila as a signal regulating 
segmental and imaginal disc patterning. Drosophila has only one hedgehog gene
whereas mammals have three – Sonic hedgehog, Indian hedgehog and Desert 
hedgehog (Shh, Ihh, Dhh) (Echelard et al., 1993; Krauss et al., 1993; Riddle et al., 
1993). They encode secreted proteins that are involved in signaling between cells. 
Hh signal transduction is mediated by transmembrane receptors Smoothened (Smo) 
and Patched, which has two genes in mammals (Ptc1 and -2). Ptc inhibits Smo but 
only when a ligand binds to Ptc this inhibition is prevented allowing signal trans-
duction. Ptc itself is also regulated by Hhs establishing a negative feedback loop. 
Signal transduction through Smo activates intracellular targets including Gli family 
zinc finger transcription factors (Gli1, -2, -3) (Ingham, 1998). Ptc1 as well as Hh 
interacting protein (Hip) also restricts Shh signaling by sequestering Shh protein. 
Hip is a membrane bound protein that binds to all three Hhs (Chuang and McMa-
hon, 1999; Cobourne and Sharpe, 2002). 
Hh in embryonic development 
In vertebrates, Hhs are involved in cell fate specification, cell survival and cell 
proliferation in different developmental processes such as limb morphogenesis, 
myotome and sclerotome specification, cartilage differentiation, hair follicle devel-
opment, regulation of left-right asymmetry, cranial neural crest survival, motor 
neuron induction and spermatogenesis (Hammerschmidt et al., 1997; reviewed by 
Ingham and McMahon, 2001). 
Ihh has rather restricted functions during development, regulating mainly skele-
tal differentation. In addition it is expressed in gut and in cartilage and is important 
for postnatal bone growth (Bitgood and McMahon, 1995; Bitgood et al., 1996). 
Dhh is involved in spermatogenesis and is expressed in Schwann cells and Sertoli 
cells of the testis. Dhh knockout mice exhibit defective spermatogenesis (Bitgood 
and McMahon, 1995; Bitgood et al., 1996; Clark et al. 2000). In contrast, Shh regu-
lates a wide variety of developmental events such as left-right asymmetry and the 
patterning of the neural tube and limbs. Shh also regulates the morphology of sev-
eral organs, predominantly epithelial structures dependent on epithelial-
mesenchymal interactions in lung (branching), hair follicle, tooth and bladder. Shh 
is expressed in three regions that have key organiser activity in the embryo: noto-
chord, floor plate and the zone of polarizing activity in the limb bud (McMahon, 
2000; Martin, 1998; Vaahtokari et al., 1996). Shh deficient mice have several de-
velopmental abnormalities including defects in craniofacial structures, neural tube 
and limbs (Chiang et al., 1996).  
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 Notch family 
Structure and function 
Notch was first identified in Drosophila as a large membrane receptor controlling 
cell fate decisions. In vertebrates four Notch homologs are known. In vertebrates 
the ligands to the Notch receptors are Jagged (Drosophila Serrate) and Delta-like 
molecules. In Notch signaling, both the ligand and receptor are transmembrane 
proteins and thus signal transduction requires intimate cell-cell contacts (Lewis, 
1998; Bray, 1998; Artavanis-Tsakonas et al., 1999). 
Ligand binding to the Notch receptor causes the release of the intracellular do-
main which translocates into the nucleus activating the target genes belonging to 
the Hes family of basic helix-loop-helix (bHLH) transcription factors, mainly Hes1
and Hes5 (Sasai et al., 1992; Takebayashi et al., 1995). Furthermore, activation of 
Notch in a given cell regulates production of Notch ligands by that cell (Lewis, 
1998; Bray, 1998; Artavanis-Tsakonas et al., 1999). 
Notch signaling activity is modified by Fringe molecules which are glycosyl-
transferases that affect the glycosylation of the molecules involved in the Notch 
signaling at the cell surface. There are three Fringe genes in mammals: Lunatic
Fringe, Radical Fringe, and Manic Fringe (Wu and Rao, 1999). The modulation 
by Fringe is context-dependent and varies between different ligands. In Droso-
phila, Fringe inhibits a cell’s ability to respond to Serrate protein (Jagged in verte-
brates) and potentiates its ability to respond to Delta protein (Panin et al., 1997). 
Notch signaling during embryonic development 
Notch signaling has been implicated in cell fate decisions and in the formation of 
tissue compartments during the development of insects and vertebrates (Artavanis-
Tsakonas et al., 1999; Mustonen et al., 2002; Baron, 2003). Fringe functions in the 
establishment of tissue boundaries in Drosophila, and it has been implicated in 
border formation in the apical ectodermal ridge (AER) signaling centers in verte-
brate limbs (Laufer et al., 1997). Interestingly, Lunatic Fringe (L-Fng) expression 
forms a sharp boundary with the enamel knot, which itself is devoid of Fringe ex-
pression. It is thus possible that L-Fng play a role in the formation of the enamel 
knot signaling center in the dental epithelium. However, tooth morphogenesis ap-
pears unaffected in L-Fng null mutant mice (Mustonen et al., 2002). 
 Wnt family 
Structure and function 
The vertebrate Wnt family contains over 20 secreted glycoproteins that are in-
volved in a variety of developmental processes such as cell proliferation, migration 
and differentiation as well as in tumorigenesis (Wodarz et al., 1998; Sharpe et al., 
2001). Wnts signal through the Frizzled family of receptors and to date more than 
ten receptors have been identified in vertebrates. Although extensive research, the 
ligand specificity and function of the receptors are still far from clear. Wnt function 
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is also extracellularly modulated by secreted Frizzled-related proteins, such as 
dickkopf, cerberus, and Wnt inhibitory factor-1. They are thought to have antago-
nist activity, although in some cases they may also act as Wnt agonists (Wang et al, 
1997; Piccolo et al., 1999; Hsieh et al., 1999; Polakis, 2000; Zorn, 2001). Wnts 
have also a co-receptor, the low-density lipoprotein receptor-related protein 
(Lrp5/6) which bind the extracellular inhibitor Dickkopf (Huelsken et al., 2001) 
After ligand binding to the Frizzled receptor, several different signal transduc-
tion pathways can be triggered and at least three different signaling cascades are 
known. In the classical, canonical, pathway, Wnt signaling through Frizzled acti-
vates the intracellular Disheveled. This leads to the inactivation of the glycogen 
synthase kinase 3 enzyme (Gsk-3) and subsequently to ?-catenin stabilisation. 
When Gsk-3 is active, it prevents ?-catenin from dissociation from the adenoma-
tous polyposis coli (APC) protein and thus targets ?-catenin for degradation. How-
ever, when Wnts signal through Frizzled, activate Disheveled and thus inhibit Gsk-
3, ?-catenin can dissociate from the APC protein and translocate to the nucleus. In 
the nucleus ?-catenin functions as a transcriptional coactivator by interacting with 
T cell factor/lymphoid enchancer binding factor (Tcf/Lef) transcription factors to 
mediate many of the effects of Wnts on gene transcription (reviewed by Krishnan 
et al., 2006). 
Notably, ?-catenin is also a structural adaptor protein linking cell-cell adhesion 
molecules cadherins to the actin cytoskeleton (Nelson and Nusse, 2004). In addi-
tion, APC functions as a tumour suppressor in adults and Gsk-3 also regulates gly-
cogen metabolism (Korinek et al., 1997; He et al., 1998).  
Wnt gene family during embryonic development 
The knowledge of the signaling and developmental functions of Wnts is based on 
the studies of the Drosophila wingless, the Wnt ortholog of the fly. Wingless is 
involved in segment polarity patterning and development of various organs. (Cadi-
gan and Nusse, 1997; Wodarz and Nusse, 1998; Huelsken and Birchmeier, 2001). 
In Xenopus Wnts are also involved in axis formation. Wnts have different abilities 
to promote secondary axis formation in Xenopus and this correlates also with the 
oncogenic potential and thus Wnts are not functionally equivalent (Polakis, 2000; 
Kuhl et al., 2000). In humans, constitutive activation of the Wnt signal transduction 
can cause cancer (Lustig and Behrens, 2003). Mutations in AXIN2, part of the ?-
catenin degradation complex, can cause severe oligodontia and predispose to colo-
rectal cancer (Lammi et al., 2004). In mice Wnts are involved in the development 
of most of the organs regulating cell proliferation, migration, differentiation and 
epithelial-mesenchymal interactions (Millar, 2002). In addition, Wnts are involved 
in skeletal development and bone remodelling (reviewed by Abe, 2006).  
Other signaling molecules 
The tumour necrosis factor (TNF) family consists of more than 15 members, most 
of which are involved in regulating host defence, immunity, and inflammation 
(Baker and Reffy, 1998; Locksley et al., 2001). TNF family members are also in-
volved in osteoclast survival and differentiation as well as terminal differentiation 
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of mammary gland alveolar buds (Filvaroff and Derynck, 1998; Fata et al., 2000). 
The identification of genes responsible for hypohidrotic (anhidrotic) ectodermal 
dysplasia (HED) syndromes has indicated that TNFs are also important regulators 
of ectodermal organogenesis (Kere et al., 1996; Headon and Overbeek, 1999; Mik-
kola et al., 1999). In ectodermal organ development two Tnf members have been 
implicated, Ectodysplasin A-1 (EDA-A1) and EDA-A2, which are splice variants of 
the same gene (Bayés et al., 1998; Yan et al., 2000). The receptor for EDA-A1 is 
EDAR (mouse Downless) and for EDA-A2 XEDAR (Headon and Overbeek, 1999; 
Yan et al., 2000). For a third receptor, TROY, the ligand is unknown (Hu et al., 
1999; Eby et al., 2000; Kojima et al., 2000). Troy is coexpressed in teeth with Edar
(Pispa et al., 2003). 
Tooth as a model for ectodermal organ development 
The early embryonic ectoderm is divided into three major domains: neural crest, 
neural tube and the surface ectoderm. The neural crest gives rise to the peripheral 
nervous system, melanocytes, most craniofacial bones and cartilage and the mesen-
chymal component of the tooth. The neural tube gives rise to the brain and spinal 
cord. The main derivative of surface ectoderm is the epidermis of the skin but also 
several other structures like oral epithelium, olfactory epithelium, lens and the cor-
nea develop from surface ectoderm. Several organs including hair, feather, tooth 
and glands are formed as appendages of the embryonic ectoderm. These structures 
are formed of the ectoderm and the underlying mesenchyme through sequential and 
reciprocal epithelial-mesenchymal interactions (Gilbert, 2006; Pispa and Thesleff, 
2003).
During development epithelial appendages protrude out of the epithelium (hair, 
teeth, feathers) or invaginate into the surrounding mesenchyme (glands including 
sweat-, saliva- and mammary glands). All these structures share similar regulatory 
mechanisms and developmental stages, such as initiation, morphogenesis and dif-
ferentiation. Accordingly, the developmental regulatory molecules are shared be-
tween these organs (Thesleff and Mikkola, 2002). 
At the initiation stage, a thickening of the epithelium forms an ectodermal pla-
code, which causes the condensation of underlying mesenchymal cells. The pla-
code will subsequently invaginate into the mesenchyme and form an epithelial bud 
(teeth, hair, and glands) except in feather development where the bud will grow out 
of the mesenchyme. The bud will then undergo morphogenesis, by growing, fold-
ing and/or branching, and attain the final size and shape of the organ. Through 
differentiation cells gain their organ specific functions and form structures such as 
dentin and enamel of teeth and secretory cells of glands (Pispa and Thesleff, 2003). 
Mammalian tooth development 
The development of mammalian dentition requires a sequence of events determin-
ing the dentition as a whole, subregions of tooth classes (e.g. incisor and molar 
regions), and morphogenesis of individual teeth within each tooth class (Jernvall 
and Thesleff, 2000). Mammals usually have three different tooth families: incisors, 
canines and molars (including premolars). Incisors have blade like crowns for cut-
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ting the food whereas canines have a more cone-shaped crown suitable for piercing 
or tearing the food. Molar crowns consist of several cusps and are used to grind and 
masticate food (Fig 3; Berkovitz et al., 2002).  
Tooth development is a good model for organ development and it has been studied 
extensively in mice. Although timing, number and final shapes of human teeth 
differ from mice, it is likely that the signal transduction pathways and molecules 
are very similar. Furthermore, the early stages of tooth development are morpho-
logically quite similar in mice and humans. In the following description of tooth 
development we mention the mouse embryonic day for each stage. 
Differences between mouse and human tooth development 
In rodents, only incisor and molar tooth families are present (Fig. 3). In the tooth-
less diastema region in rodents, between the incisors and molars, rudimentary tooth 
germs develop which are arrested by the bud stage and eventually removed by 
apoptosis (Tureckova et al., 1995; Keränen et al., 1999). In each jaw quadrant ro-
dents have one incisor and humans have two, and both have three molars (Fig. 3). 
The incisors of rodents are continuously erupting in contrast to human incisors. 
Furthermore, the rodent incisors are different in having enamel only on the labial 
surface.
human jaw
secondary dentition
primary dentition
Fig. 3. Schematic drawings of mouse and human dentitions 
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Primary and secondary dentition 
Rodents have only one dentition whereas most mammals have two, deciduous and 
permanent teeth (Fig. 3). The permanent incisors, canine and premolars form from 
the dental lamina at its deepest extremity. The proliferating activity in the dental 
lamina leads to the formation of another tooth bud on the lingual aspect of the de-
ciduous tooth germ. The molars of the permanent dentition have no deciduous 
predecessors and thus are formed as a backward extension of the dental lamina 
forming the first, second and third molar (Ten Cate, 1998). Permanent dentition is 
predominantly affected in human hypodontia which can be diagnosed in up to 8 % 
of the population, if wisdom teeth are not included (Thesleff and Pirinen, 2004).  
Initiation of tooth development 
Mammalian tooth development is initiated from the ectoderm covering the maxil-
lary, frontonasal and mandibular processes, where the dental lamina is formed. The 
dental lamina can be distinguished in mouse at embryonic day 10.5 (E10.5) as a 
horseshoe-shaped epithelial thickening. The mesenchymal component of the max-
illa and mandible is derived from the neural crest cells that have migrated from the 
posterior midbrain and anterior hindbrain (Imai et al., 1996; Chai et al., 2000; 
Zhang et al., 2003). Classical tissue recombination experiments have demonstrated 
that the early stage oral epithelium (E9-11) possesses the odontogenic potential. 
After initiation stage, at E12, the odontogenic potential shifts to the mesenchyme 
(Mina and Kollar, 1987; Lumsden, 1988). 
The complete picture of the signaling network leading to tooth induction is not 
known yet although extensive research has been conducted (Fig. 4). Antagonistic 
signaling between Bmps and Fgfs regulates various developmental processes in 
limbs and facial processes (Niswander and Martin, 1993; Buckland et al., 1998). 
Fgf8 is expressed in the oral ectoderm and may be involved in the regional specifi-
cation of the oral side of the maxillary and mandibular arch by inducing and regu-
lating mesenchymally expressed transcription factors Lhx6 and Lhx7 (Grigoriou et 
al., 1998).  
In addition, Fgf8 stimulates and Bmp2 and Bmp4 inhibits Pax9 expression in 
the mouse E10 branchial arch mesenchyme, which has also been suggested to de-
termine the correct positions of individual tooth buds within the dental lamina 
(Neubuser et al., 1997).  
Pax-9 is a paired box transcription factor and its expression is restricted to the 
future tooth mesenchyme prior to any morphological signs of tooth development 
(E10.5). However, in Pax9 deficient mice, the tooth buds do form in the dental 
lamina at the right locations, although tooth development does not proceed further 
(Peters et al., 1998). This indicates that other factors also contribute to the localisa-
tion of the tooth buds within the dental lamina. Indeed, other genes are more re-
stricted to the dental lamina, such as the transcription factor Pitx2 (Otlx2, Rieg)
(Mucchielli et al., 1997). In mice deficient of Pitx2, the development of maxillary 
teeth is arrested at placodal stage and mandibular teeth are arrested at bud stage. In 
addition, in humans, haploinsufficiency of PITX2 is associated with Rieger syn-
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drome characterized by several missing teeth (oligodontia) (Semina et al., 1996; 
Flomen et al., 1998; Lin et al., 1999).  
Antagonistic signaling between Shh and Wnt has been demonstrated to be in-
volved in the definition of boundaries of developing tooth germs. Shh expression is 
restricted to the dental lamina of future incisor and molar regions at early stage and 
is later confined to the tips of the tooth buds (E11.5-14.5). In contrast, Wnt7b is 
expressed throughout the oral epithelium but is absent in the Shh expressing tooth 
forming regions (Sarkar et al., 2000; Hardcastle et al., 1998, Keränen et al., 1999). 
It has been suggested that Wnt7b restricts Shh expression to act locally in specific 
tooth forming regions where Shh stimulates cell proliferation required for the tooth 
bud formation (Gritli-Linde et al., 2001; Hardcastle et al., 1998; Sarkar et al., 
2000).  
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Fig. 4. Schematic representation of the signals and transcription factors mediating the recip-
rocal signaling between epithelium and mesenchyme during advancing tooth development. 
Determination of tooth identity 
It has been suggested that neural crest cells may be specified first as odontogenic 
lineage and later further regionally specified as maxilla/mandible/molar/incisor 
(Weiss et al., 1998; Tucker and Sharpe, 1999). Tissue recombination experiments 
have given an indication that the early dental epithelium and not the neural crest 
determines the tooth type (Kollar and Mina, 1991) but more recently early neural 
crest in mouse was shown to induce teeth in chick (Mitsiadis et al., 2003). Fgf8 
from the oral ectoderm induces the transcription factor Barx1 in the molar region 
whereas Bmp4 inhibits the expression in the incisor region. The epithelial Bmp4 
induces Msx1 in the incisor area. After inhibiting Bmp4 in the incisor region with 
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Noggin at E9-E10, the Barx1 expression extended to the incisor area leading to the 
transition from incisor to molar (Tucker et al., 1998). This supports the theory that 
the oral ectoderm determines the tooth phenotype. 
It has been suggested that dynamic patterns of signal molecules in the early fa-
cial process result in differential activation of key transcription factors. For in-
stance, specific combinations of homeobox containing transcription factors might 
determine the identity of teeth (Tucker and Sharpe, 1999). There are a number of 
homeobox containing genes with overlapping and region-specific expression pat-
terns in the facial ectomesenchyme, such as Alx3, Barx1, Dlx1,-2,-3,-5, -6,-7, Pitx2, 
Msx1,-2, Lhx7,-7 and Gsc. They are expressed prior to the first morphological signs 
of tooth development but also during later stages (Cobourne and Sharpe, 2003). 
A great number of transcription factors have been identified as targets for early 
epithelial signals in branchial arch mesenchyme. Fgfs induce the expression of 
homeobox genes Lhx6,-7, Msx1,-2 and Dlx1,-2, Bmps upregulate Msx1,-2 and 
Dlx1, -2 whereas Shh induces Gli1,-2, and -3 (Bei and Maas, 1998; Hardcastle et 
al., 1998; Tucker et al., 1999). 
Several of the above mentioned molecules have been shown to be essential for 
tooth development at early stage, because deletion of their function in knockout 
mice results in a arrest of tooth development at the dental lamina stage. However, 
only double knockouts where functions of two genes have been deleted, such as 
both Msx1 and Msx2 cause an arrest of development at this stage. Similarly, Gli2
and -3 double knockouts arrest also at the dental lamina stage except for the upper 
incisors that grow to bud stage. In addition, a double knockout of both Dlx1 and -2
results in similar arrest at dental lamina stage except that it only affects maxillary 
molars (Thomas et al., 1997; Bei and Maas, 1998; Hardcastle et al., 1998). There-
fore Msx1-2, Gli2-3 and Dlx1-2 transcription factors are probably functionally 
redundant because only when both genes are knocked out, an early tooth develop-
ment arrest phenotype is seen. Although Dlx1 and -2 are expressed both in the up-
per and lower molar regions, Dlx5 and -6 are present only in the lower molars 
(Thomas et al., 1997; Weiss et al., 1998). This suggests that the latter genes com-
pensate for the loss of Dlx1 and 2 in the lower jaw resulting in the phenotype only 
in the upper jaw.  
Dental placode - the early signaling center
After a specific tooth type has been specified at a regionally specific location 
within the dental lamina, a thickening of the epithelium takes place (E11). The 
local thickening will then grow and protrude into the mesenchyme as an epithelial 
bud. Before the bud stage, epithelial signals induce mesenchymal signals that then 
act reciprocally on the dental epithelium to form the signaling center, also called a 
dental placode (Fig. 5). Other ectodermal organs have similar structures that share 
the morphological and molecular similarities with the dental placode (Pispa and 
Thesleff, 2003). The placode expresses locally several genes, including Bmp2,
Shh,Wnt10a, p21, Msx2 and Lef1 (Jernvall and Thesleff, 2000) (Fig. 4). The early 
signaling center in tooth is similar to the apical ectodermal ridge in the limb bud 
and isthmus in central nervous system, as they regulate the behaviour of surround-
ing cells. At this stage, E11.5-E12, also the potential to instruct tooth development 
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shifts from the epithelium to mesenchyme (Mina and Kollar, 1987). Furthermore, it 
has been suggested that the mesenchyme may acquire the full competence to in-
duce tooth development only after signals are received from the dental placode 
(Jernvall and Thesleff, 2000).  
Bmp4 and Activin ?A have been proposed to be the key signals from the mes-
enchyme to induce the epithelial signaling center and subsequent budding of the 
tooth (Jernvall and Thesleff, 2000). Epithelial Bmp4 induces the mesenchymal 
Bmp4 expression via Msx1 and this shift of expression from epithelium to mesen-
chyme (E11.5) coincides with the shift of the potential to instruct tooth develop-
ment (Mina and Kollar, 1987; Vainio et al., 1993). Simultaneously, Msx1 expres-
sion that have been widely expressed throughout the facial mesenchyme, becomes 
restricted to the tooth bud regions in the mesenchyme (Cobourne and Sharpe, 
2003). In addition, Bmp4 induces p21 in the dental placode. p21 is associated with 
the stop of cell proliferation and is expressed in several other signaling centers 
(Jernvall et al., 1998). Transgenic mice with deleted function of Activin ?A, which 
is expressed in the mesenchyme and induced by epithelial Fgf8, show a phenotype 
opposite to the Dlx1-2 double knockout and all teeth except upper molars are ar-
rested at early bud stage (Ferguson et al., 1998). In addition, exogenous Activin ?A
protein can rescue tooth development in the mutants but only when implemented at 
E11.5 and not later, which suggests that it has a key function in the initiation of the 
epithelial budding (Ferguson et al., 1998). Furthermore, in mice lacking p63, all 
ectodermal organs fail to develop, including tooth and hair. The dental lamina is 
formed in the p63 -/- mouse but no tooth buds are formed (Laurikkala et al., 2006). 
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Fig. 5. Schematic representation of the stages of early morphogenesis of first molar tooth. 
oe, oral epithelium; dl, dental lamina; pl, dental placode; dm, dental mesenchyme; de, den-
tal epithelium; ode, outer dental epithelium; df, dental follicle; ek, enamel knot; ide, inner 
dental epithelium; dp, dental papilla; eo, enamel organ. 
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Enamel knot and bud to cap transition 
After the dental placode has formed, the epithelial bud grows into the mesenchyme 
and at E13 it has reached its full vertical height. Subsequently the tip of the bud 
flattens due to the growth of the width of the bud. Simultaneously a new signaling 
center is formed, the primary enamel knot (E13.5-E14), at the tip of the widened 
bud (Fig. 5). The primary enamel knot is a non-proliferating transient structure that 
is thought to regulate the growth of the flanking epithelial cervical loops which 
invaginate and form a cap-shaped structure, surrounding the mesenchymal dental 
papilla (cap stage of tooth development) (Jernvall et al., 1998).  
The transition from bud to cap stage is a critical step in tooth development and 
requires reciprocal and sequential signaling between the epithelium and mesen-
chyme. Interruption of this signaling leads to an arrest of tooth development at this 
stage shown in several knockout mice such as Msx1, Lef1, Pax9, and Activin ?A
(Jervall and Thesleff, 2000) (Fig. 4). In all these mutants, the formation of the 
enamel knot has been impaired which suggests that it is a prerequisite for the tooth 
bud to develop into cap stage. Interestingly, a common feature of the knockouts of 
transcription factors Msx1 and Pax9 is that Bmp4 is missing from the dental mes-
enchyme. This indicates that Bmp4 is a good candidate for the mesenchymal signal 
inducing the transition from bud to cap stage (Jernvall and Thesleff, 2000). This is 
also supported by experiments in which addition of exogenous Bmp4 can rescue 
the arrest at bud stage of Msx1 mutant embryos (Bei et al., 2000).  
The primary enamel knot expresses, when formed at E13.5-E14, mRNA of sev-
eral genes such as Fgf9, Bmp2, Bmp7, Shh, Wnt10a, Msx2, Edar, p21 and Fol-
listatin (Vaahtokari et al., 1996; Kettunen and Thesleff, 1998; Dassule and McMa-
hon, 1998; Laurikkala et al., 2001; Jernvall et al., 1998; Heikinheimo et al., 1997). 
In addition, at cap stage (E14-E14.5), when the enamel knot is histologically dis-
tinguishable as a cluster of condensed cells at the tip of the tooth germ, also some 
additional genes are expressed including Fgf3, Fgf4, Bmp4, Wnt3 and Wnt10a 
(Kettunen and Thesleff, 1998; Sarkar and Sharpe, 1999; Jernvall et al., 1998). Sig-
nal pathways of Bmp, Fgf, Shh and Wnt families have been shown to be integrated 
at different levels in tooth development and they partly activate the same transcrip-
tional targets. Both Fgfs and Bmp4 activate Msx1 and Dlx2, although Msx2 is only 
activated by Bmp and Dlx1 by Fgf (Vainio et al., 1993; Bei and Maas, 1998; Ket-
tunen and Thesleff, 1998). Furthermore, it has been suggested that Lef1 may inte-
grate Wnt and Bmp signaling as both can induce Lef1 in the mesenchyme and Lef1 
interacts intracellularly with ?-catenin, which in turn can regulate cell adhesion 
with E-cadherin (Dassule and Macmahon, 1998). Shh has been shown to repress 
Wnt10b expression in the dental epithelium and Shh receptor Ptc, which is regu-
lated by Shh, require Msx1 in the mesenchyme (Dassule and McMahon, 1998; 
Zhang et al., 1999). 
Fgf have been suggested to be involved in the proliferation of the cervical loops 
and subsequent growth. All studied Fgfs function as mitogens in cultured dental 
tissues but epithelial Fgf4 and Fgf9 can stimulate proliferation of both epithelium 
and mesenchyme, whereas mesenchymal Fgf10 can only stimulate epithelial cells 
(Jernvall and Thesleff, 2000). Abundance of Fgf receptors in the cervical loops and 
dental papilla suggest that these are target tissues, and this is in line with the distri-
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bution of dividing cells in the tooth germ (Jernvall and Thesleff, 2000). The enamel 
knot expresses several growth stimulating signals, including Fgf4, Fgf3 and Fgf9,
while its cells remain non-proliferating themselves. This is probably due to the lack 
of Fgf receptors in the enamel knot itself (Jernvall et al., 1998; Kettunen and 
Thesleff, 1998). p21 is also expressed in the enamel knot and is thought to be in-
volved in the differentiation and withdrawal from the cell cycle (Jernvall et al., 
1998). Interestingly, p21 is also expressed in AER which is another signaling cen-
ter expressing Fgfs while remaining itself non-proliferative (Parker et al., 1995). 
The reciprocal Fgf signaling between epithelium and mesenchyme regulating gene 
expression within the same signal family is similar as in limb development (Xu et 
al., 1998). It has been shown that Lef1 is a critical survival factor for the dental 
epithelium during tooth morphogenesis (Sasaki et al., 2005). In Lef1 mutants Fgf4
is missing in enamel knot and Fgf3 in dental mesenchyme and Fgfs can rescue the 
arrest of tooth development in Lef1 mutants (Kratochwil et al., 1996, 2003).  
Secondary enamel knots and cusp formation 
The primary enamel knot is a transient structure that is removed by apoptosis be-
ginning from the distal/posterior end and proceeding until only the anterior portion 
remains. After primary enamel knot removal in teeth with more than one cusp (e.g. 
molars), new, secondary enamel knots form at the sites of future cusp tips. In this 
so-called bell stage, from E15 onwards, cervical loops grow downwards into the 
mesenchyme. Secondary enamel knots are non-proliferative, express Fgf4 and are 
removed by apoptosis, similar to primary enamel knots (Vaahtokari et al., 1996; 
Coin et al., 1999b). The apoptosis in the enamel knot is associated with the expres-
sion of Bmp4 which precedes the apoptosis of the knot cells. Apoptosis has been 
suggested to be a mechanism controlling the duration of the signaling, similar to 
the removal of the AER in the limb bud (Pizette and Niswander, 1999). Bmp4 
regulates also apoptosis in other events during development, e.g. in rhombomeres 
and formation of digits (Smith and Graham et al., 2001; Guha et al., 2002). 
Fgf4 expression is a good marker for secondary enamel knots and is strictly lim-
ited to the cusp tips whereas Shh, p21, Fgf9 and mesenchymal Bmp4 have more 
diffuse expression domains (Jernvall and Thesleff, 2000). Comparison between 
two mammalian species with different molar morphology suggested that the cusp 
patterning begins as early as E15, after removal of primary enamel knot, before any 
cusp development is evident morphologically (Keranen at al., 1998).  
Secondary enamel knots form in a species-specific pattern and will dictate the fu-
ture cusp pattern (Jernvall et al., 2000). The spacing of the secondary enamel knots 
must be accurately controlled as this determines the correct cusp position and size 
resulting in a functional, specific tooth shape in each species (Jernvall and Thesleff, 
2000).
Bmps have been suggested to play a role in formation of periodic patterns by 
inhibiting the spreading of Fgf signaling (Jung et al., 1998). It has been suggested 
that in tooth, Fgf4 functions as cusp activator while Bmps and possibly Shh could 
function as inhibitors regulating the distance between the cusps (Jernvall and 
Thesleff, 2000). Shh signaling was shown to be essential for asymmetrical growth 
of the enamel organ (Dassule et al., 2000). However, it has been suggested that the 
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action of Shh on the dental epithelium is indirect and acts on the dental mesen-
chyme that reciprocally regulates growth of the epithelial cervical loops (Gritli-
Linde et al., 2002).  
More insight in cusp formation and patterning has been attained from studies of 
Tabby mutant mice with defects in cusp patterning. Tabby gene is the mouse homo-
logue of the HED gene EDA and encodes a protein called Ectodysplasin, which is a 
member of the Tnf ligand superfamily (Mikkola et al., 1999; Pispa and Thesleff, 
2003). Both HED patients and Tabby mice are characterized by abnormal devel-
opment of epithelial appendages such as teeth, hair, and sweat glands. The cusp 
pattern in Tabby mice molars is compressed as the tips of the cusps are close or 
united to each other. Furthermore, the last developing cusps as well as the third 
molar are often missing (Jernvall and Thesleff, 2000). It has been proposed that the 
cause of the tooth phenotype of Tabby mice is the small size of the tooth germ and 
subsequently small primary enamel knot. Supporting this is the observation that the 
Tabby enamel knot express all the knot signals analyzed but is greatly reduced in 
size (Pispa et al., 1999). 
In addition, the central role of Tgf?/Bmp signaling in cusp patterning has also 
become evident from the aberrant shapes of molars in the Follistatin transgenic 
mice. Imbalance between the amount of Activins/Bmps and their inhibitor Fol-
listatin has been suggested to cause abnormal proportion of activators and inhibi-
tors of normal enamel knot formation and thus abnormal cusp patterning (Wang et 
al., 2004). Computer modelling of the function of activators and inhibitors indi-
cates that the cusp pattern of different animal species can be mimicked by fine-
tuning of their activities (Salazar-Ciudad and Jernvall, 2002). Further evidence of 
the importance of the correct ratio between activators and inhibitors have been 
shown in studies of mice with deleted Ectodin function (Kassai et al., 2005). Ecto-
din is a Bmp inhibitor and also a Wnt signaling modulator and these mice have 
severe cusp patterning defects (Kassai et al., 2005). 
Cell differentiation and mineralisation 
During tooth cusp morphogenesis, the cells at the border between the inner enamel 
epithelium and the dental papilla mesenchyme begin to differentiate to ameloblasts 
and odontoblasts. The differentiation process begins in mouse at E16 and continues 
in the cervical direction until the root starts to develop. The differentiation of odon-
toblasts and ameloblasts is regulated by reciprocal epithelial-mesenchymal interac-
tions, and the same signal molecules associated with morphogenetic regulation 
have also been linked with dental cell differentiation.  
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Fig. 6. Schematic representation of cell differentation during first molar tooth development. 
od, odontoblast; d, dentin; e, enamel; am, ameloblast; si, stratum intermedium; sr, stellate 
reticulum; ode, outer dental epithelium; df, dental follicle; dp, dental papilla. 
Odontoblasts
Preodontoblasts are initially cylinder-shaped and organised as a single layer adja-
cent to the inner enamel epithelium. During differentiation, the preodontoblasts 
elongate and polarize becoming odontoblasts that are tall columnar cells (Fig. 6). 
Odontoblasts secrete dentin matrix consisting of mainly type I collagen but also 
non-collagenous proteins including proteoglycans, glycoproteins and dentin sialo-
phosphoprotein (DSPP) (D'Souza et al., 1997). 
Odontoblast differentiation is regulated by the inner dental epithelium (Fig. 5) 
(Thesleff and Hurmerinta, 1981; Ruch et al., 1995). Since odontoblast differentia-
tion begins in the mesenchymal cells adjacent to the secondary enamel knots, it has 
been proposed that signals from the secondary enamel knot regulate the initiation 
of terminal differentiation of odontoblasts (Jernvall and Thesleff , 2000). Signals in 
the Tgf? and FGF families have been implicated in odontoblast differentiation. In
vitro experiments have shown that Tgf?1 and -3 and Bmp2, -4 and -6 can induce 
polarization of preodontoblasts and stimulate dentin matrix secretion (Begue-Kirn 
et al., 1992; Ruch et al., 1998). 
Ameloblasts 
Preameloblasts are derived from precursor cells of the inner dental epithelium of 
the enamel organ and during differentiation into secretory ameloblasts they become 
highly columnar and polarized with oval-shaped nuclei elongated along the apical-
basal axis (Fig. 6) (Ten Cate, 1998). Functional ameloblasts secrete a number of 
enamel matrix proteins, including amelogenin, ameloblastin, enamelin, tuftelin, 
DSPP, laminin 5 as well as proteolytic enzymes (Robinson et al., 1998). When the 
enamel matrix deposition is complete, the secretory ameloblasts shrink in size. 
During maturation even 25 % undergo apoptosis and the remaining cells, together 
with the outer enamel epithelium, form a protective layer on the enamel until the 
tooth has erupted (Joseph et al., 1999).  
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Again, reciprocal epithelial-mesenchymal interactions regulate ameloblast differen-
tiation and presence of functional odontoblasts and/or predentin-dentin is required. 
Secretion of enamel matrix is only initiated when dentin matrix begins to mineral-
ize (Coin et al., 1999a). Ameloblast and odontoblast cytodifferentation can be in-
duced by Tgf?1, Bmp2 and Bmp4 (Begue-Kirn et al., 1992,1994; Wang et al., 
2004). It was recently shown that the main signal from odontoblasts inducing 
ameloblast differentation is Bmp4, and that Activin emanating from the dental 
follicle antagonices the effect of Bmp4 (Wang et al., 2004). In addition, overex-
pression of Smad2 in the epidermis under keratin 14 promoter resulted in abnormal 
enamel structure (Ito et al., 2001). It has also been shown that Shh is necessary for 
regulating cell proliferation within the dental epithelium and controlling cytodiffer-
entation of preameloblasts (Gritli-Linde et al., 2002).  
Bone development 
Most of the craniofacial skeleton is of neural crest origin, except for the otic and 
occipital region and the parietal bones that are derived from cephalic and somitic 
mesoderm (Couly et al., 1993; Chai et al., 2000). Bone development begins with 
the formation of mesenchymal condensations at sites of future bones, consisting of 
cells that can differentiate into either chondroblasts or osteoblasts (reviewed by 
Hall and Miyake, 2000). In mouse, condensations appear between E10.5-E12.5 and 
subsequently bone formation begins by intramembranous or endochondral mecha-
nism (reviewed by Karsenty, 1998). Most bones form through endochondral ossifi-
cation but in the facial area intramembranous bone formation predominates. Muta-
tions in the genes encoding paracrine factors, their receptors and transcription fac-
tors that regulate these ossification processes, cause numerous craniofacial devel-
opmental abnormalities (reviewed by Rice, 2005). 
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Fig. 7. Schematic representation of molecular regulation of chondroblast and osteoblast 
differentation (modified from Kobayashi and Kronenberg, 2005). Transcription factors 
important for certain stages are indicated by a box. Signal molecules are indicated with a 
arrow.
 31
Endochondral ossification 
First stage of endochondral ossification is the commitment of mesenchymal cells to 
become cartilage cells. This is caused by paracrine factors inducing two transcrip-
tion factors, Pax1 and Scleraxis, that are thought to activate cartilage specific genes 
(Cserjesi et al., 1995; Sosic et al., 1997). Subsequently, the committed mesenchy-
mal cells condensate into compact nodules and differentiate to chondrocytes. It has 
been suggested that N-cadherin is involved in the initiation of these condensations, 
and that N-CAM is critical for maintaining them (Oberlender and Tuan, 1994; Hall 
and Miyake, 2000). Sox9 is required for cartilage differentiation and expression of 
chondrocyte-specific genes that encode cartilage extracellular matrix components, 
including collagen types II, IX, and XI, and aggrecan (Åberg et al., 2005). The 
stages of chondrocyte differentiation are regulated by a complex series of signaling 
molecules and transcription factors in addition to Sox9 and Runx2/3 (Fig. 7). Sig-
naling molecules involved in chondrocyte differentiation include Bmps, Fgfs, Ihh 
and Wnts. Transcription factors involved include L-Sox5, Sox6, Dlx5 and Dlx6 
(Fig. 7) (reviewed by Kobayashi and Kroneberg, 2005). During the next phase, 
chondrocytes proliferate to form the cartilage model for the bone and simultane-
ously secrete a cartilage specific extracellular matrix. In the next phase, the chon-
drocytes increase their volume and become hypertrophic chondrocytes and altered 
matrix production enables calcification of the cartilage. Runx2 and Runx3 are the 
major transcription factors regulating chondrocyte hypertrophy (Fig. 7) (Kobayashi 
and Kroneberg, 2005). The chondrocytes are eventually removed by apoptosis 
(Hatori et al., 1995). In the last phase blood vessels invade the cartilage model and 
induce the differentiation of osteoblasts. Paracrine factors induce the expression of 
Runx2 which is essential for the osteoblast differentiation (Otto et al., 1997). Hy-
pertrophic chondrocytes also secrete the angiogenesis factor, Vegf, which stimu-
lates vascularisazion (Gerber et al., 1999; Haigh et al., 2000).Transcription factors 
required for osteoblast differentation are Runx2 and Osterix, which is a down-
stream target of Runx2 (Kobayashi and Kronenberg, 2005). Recently ?-catenin,
which is part of canonical Wnt signaling, has been shown to be important for vari-
ous stages of osteoblast differentiation (reviewed by Kobayashi and Kronenberg, 
2005). In addition, Dlx5, Msx1, Twist, Alx4 and androgen and estrogen receptors 
have been shown to affect the osteoblast differentiation (reviewed by Kobayashi 
and Kronenberg, 2005). The osteoblasts begin secreting bone matrix constructing a 
bone collar around the cartilage. Eventually, the cartilage is replaced by bone. 
Bone formation takes place also at the surface of the bone, in the periosteum, 
where no cartilaginous model exists. The shapes of bones are modified by this in-
tramembranous-like process (reviewed by Gilbert, 2006).  
Intramembranous ossification 
In the skull, the calvarial, maxillary, mandibular, and facial bones are formed by 
intramembranous ossification. In addition, also a large part of the clavicle is 
formed by the same mechanism. In intramembranous ossification, the mesenchy-
mal cells condense into compact nodules, and the central cells differentiatiate into 
osteoblasts which secrete bone extracellular matrix and form ossification centers. 
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Intramembranous bone formation is regulated by transcription factors Runx2 and 
Osterix similarly as osteoblast differentation in endochondral bone formation (Fig. 
7) (reviewed by Kobayashi and Kroneberg, 2005). In addition, signaling molecules 
in the Bmp and Fgf families regulate formation of intramembranous calvarial 
bones and suture fate (reviewed by Rice, 2005). Those osteoblasts that become 
embedded in the calcified matrix become osteocytes. A single bone may have sev-
eral ossification centers that fuse to form the final bone (reviewed by Kaufmann 
and Bard, 1999). Surrounding the bone is the periosteum that is a membrane of 
compact mesenchymal cells. Cells at the inner surface of the periosteum differenti-
ate into osteoblasts and subsequently growth is achieved. Similarly to endo-
chondral ossification, induction of Runx2 is essential for osteoblast differentiation 
and subsequent bone formation (Otto et al., 1997). 
Cleidocranial dysplasia and Runx2
Structure and function of Runx genes 
The Runx gene family of transcription factors comprise a small group of genes 
characterized by a DNA-binding Runt domain that is highly conserved among dif-
ferent species. In Drosophila, two runt domain genes are known, Runt and Looz-
enge and additionally two more have been found that are still functionally unchar-
acterized (reviewed by Coffman, 2003). The mammalian Runx genes are homologs 
of the Runt domain transcription factor family in Drosophila. In mammals, three 
Runx genes are known; Runx1 (Cbfa2/Pebp2aB/Aml1), Runx2 
(Cbfa1/Pebp2aA/Aml3) and Runx3 (Cbfa3/Pebp2aC/Aml2). The three Runx genes 
are very similar with respect to their genomic organisation and DNA sequence 
(Bangsow et al., 2001; Levanon et al., 2001; Thirunavukkarasu et al., 1998).
Mammalian Runx genes exhibit two alternative promoters (P1 and P2) and subse-
quently two different Runx isoforms can be produced with possibly distinct func-
tions (Bangsow et al., 2001; Coffman, 2003). In Runx2, type II isoform transcrip-
tion is initiated at the distal P1 promoter, while type I isoform transcription is initi-
ated at the proximal P2 promoter (reviewed by Stock and Otto, 2005). Type I iso-
form (pebp2?A) was originally cloned as a T-cell-specific factor but is also ex-
pressed in other non-osseus tissues and in osteoblasts, and type II isoform (Osf2, 
til1) as a osteoblast specific factor (reviewed by Stock and Otto, 2005). Also a third 
potential N-terminal isoform in mouse has been described (Ducy et al., 1997). In 
addition, the primary type I and II transcripts are processed into several alterna-
tively spliced mRNA isoforms that are differentially expressed in various cell types 
and at different developmental stages. The role and biological relevance of these 
different isoforms are still unknown (reviewed by Stock and Otto, 2005). Also 
other mammalian Runx genes can generate alternatively spliced transcripts with 
possibly different roles during embryogenesis (Levanon et al., 1996; Bangsow et 
al., 2001). The functional transcription factor is a heterodimer of two subunits, ?-
subunit encoded by the Runx genes in mammals, and the ?-subunit (CBF?) which 
is encoded by only one gene but appears in the mouse as three alternatively spliced 
products (Nagata and Werner, 2001). CBF? does not bind to DNA itself but can 
enhance the DNA binding affinity of Runx proteins and also possibly stabilize 
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Runx from degradation (Coffman, 2003; reviewed by Ito and Miyazono, 2003). 
The CBF? subunit is essential for the function of Runx proteins (Huang et al., 
2001).  
The ?-subunit (Runx) has the DNA binding domain Runt, which is a 128 amino 
acid motif (Fig. 8). The runt domain directs DNA binding of Runx proteins, and 
also contributes to protein-protein interactions, ATP binding, and nuclear localiza-
tion (reviewed by Stock and Otto, 2005). Furthermore, the N-terminal region is 
rich in glutamine and alanine repeats (Q/A) (Fig. 8). In the C-terminal region is a 
proline/serine/threonine rich region (PST), which is necessary for nuclear matrix 
targeting, transcriptional activation or repression of target genes, and also contains 
MAP kinase phosphorylation sites (reviewed by Stock and Otto, 2005). In addition, 
most Runx genes terminate with a common pentapeptide, VWRPY, which can 
recruit the Groucho/TLE family of corepressors (Fig. 8) (Levanon et al., 1998; 
Javed et al., 2001) 
Runx transcription factors bind to several DNA motifs, such as PyGPyGGT, on 
a number of enhancers and promoters, including murine leukemia virus and polyo-
mavirus enhancer (Ducy et al., 1997; Karsenty and Wagner, 2002). In addition, 
Runx2 has been shown to bind to the OSE2 DNA motif AACAC within the 
5´regulatory regions of genes (Ducy et al., 1997). Binding partners for Runx2 in-
clude DNA binding partners, chromatin remodelling factors (histone deacetylase 5) 
and mediators of signal transduction pathways (YES-associated protein) (Westen-
dorf, 2006).  
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Fig. 8. Schematic representation of the Runx2 protein. Runx2 protein is composed of a 
glutamine/alanine-rich region (Q/A) in the N-terminal region, a centrally located DNA 
binding domain (Runt domain) and nuclear localization signal (NLS), and the C-terminal 
proline/serine/threonine-rich PST region containing transactivation and repression domains 
and a nuclear matrix targeting signal domain. 
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Runx genes in embryonic development 
Runt and Lozenge control a large number of developmental processes in Droso-
phila. Runt is part of a network of signals that control pattern formation in the em-
bryo. In the central nervous system, Runt function is necessary for the development 
of a subset of neurons. In addition, Runt is also a key regulator of sex determina-
tion. Lozenge controls pre-patterning and cell-fate choices in the development of 
the visual system and is also required in haematopoiesis for the specification of a 
Drosophila blood cell lineage (Coffman et al., 2003).  
In humans RUNX1 is essential for angiogenesis and mature haematopoiesis and
is most frequently involved in acute leukemia (Otto et al., 2003; reviewed by Ito, 
2004). Runx1 knockout mice exhibit early embryonic lethality with massive haem-
orrhage due to lack of definitive haematopoietic stem cells and defective angio-
genesis (reviewed by Ito, 2004). Also the ?-subunit, CBF?, is frequently involved 
in chromosome rearrangements associated with human leukemia (reviewed by Ito, 
2004). Runx3 is involved in neurogenesis, thymopoesis and in addition, a possible 
candidate to be a gastric cancer tumour suppressor (reviewed by Ito, 2004). The 
function of Runx proteins during development was first discovered when several 
research groups confirmed that Runx2 is a key regulator of osteoblast differentia-
tion and bone formation (Ducy et al., 1997; Mundlos et al., 1997; Otto et al., 1997; 
Komori et al., 1997).  
Runx2 knockout mice die soon after birth and show no osteoblast differentiation 
and hence completely lack bone (Komori et al., 1997; Otto et al., 1997). Runx2 
activity is needed for osteoblast differentiation in both intramembranous and endo-
chondral bone formation where it also has a positive role in the differentiation of 
hypertrophic chondrocytes (reviewed by Kobayashi and Kroneberg, 2005). Runx2 
is a transcriptional activator of osteoblasts and activates most osteoblastic markers, 
including osteocalcin, type I collagen and collagenase (Ducy et al., 1997); Runx2
expression is both necessary and sufficient for osteoblast differentiation (Ducy et 
al., 1997). RUNX2 haploinsufficiency is the cause of CCD in humans and inactiva-
tion of one Runx2 allele in mice causes a similar skeletal phenotype (Mundlos et 
al., 1997; Otto et al., 1997). In addition, a mouse deficient for type II isoform of 
Runx2 have been generated by targeted disruption of the P1 promoter. The pheno-
type showed disturbances mainly in endochondral ossification in contrast to total 
Runx2 heterozygous knockout mice that exhibit disturbance in intramembranous 
ossification. (reviewed Stock and Otto, 2005). CBF? is required for Runx2 function 
during skeletal development and thus CBF? mutations can also cause CCD-type 
phenotype (reviewed by Rice, 2005). 
Regulation of Runx2 
Bmps that are inducers of osteoblast differentiation and bone formation upregulate 
Runx2 expression in osteoblasts (Ducy et al., 1997). Runx2 mediates Bmp-induced 
osteogenic signaling pathway and is essential for Bmp signaling and regulation of 
downstream target genes (Afzal et al., 2005;). The activity of Runx2 can also be 
altered by direct interactions with other transcription factors such as Smads and 
AP1 factors (reviewed by Stock and Otto, 2005). Tgf? has also been shown to re-
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press Runx2 function through Smad3 (Kang et al., 2005). Runx2 can form a com-
plex with Smads and function synergistically to regulate the target gene (Ito and 
Miyazono et al., 2003). Furthermore, ?-catenin/TCF1 regulates directly Runx2 in 
stimulation of bone formation (Gaur et al., 2005). There is recent evidence that a 
complex interaction between Wnt/?-catenin and Bmp/Tgf? signal transduction 
occurs in the development of several tissues, including the skeleton and it has been 
proposed that these pathways converge in Runx2 to promote osteoblast differenta-
tion (Gaur et al., 2005). 
In addition, Runx genes can bind to the same DNA motifs and interact with a 
common transcriptional modulator (Ito, 1999). Furthermore, all Runx genes contain 
Runx binding sites in their promoter region. Hence it is possible that both positive 
and negative cross-regulation exists among Runx proteins (reviewed by Otto et al., 
2003). Furthermore the transcription factors Msx2, Bapx1, Hox1-2 and PPAR?2
have been shown to regulate Runx2 expression (reviewed by Otto et al., 2003). 
Runx2 is also regulated by Stat1 that interacts with Runx2 latent form in the cy-
toplasm, inhibiting nuclear localization and thus its nuclear transcriptional activity. 
Consequently, Stat1-deficient mice exhibit accelerated osteoblast differentiation 
which results in increased bone mass (Kim et al., 2003). Runx2 is inhibited by 
Twist, which is expressed in osteoprogenitor cells but not in mature osteoblasts and 
has been suggested to act as a negative regulator of osteogenesis (Rice et al., 2000; 
Yousfi et al., 2002). Loss-of-function mutations in Twist result in craniosynostosis, 
a condition with excessive osteogenesis of the calvarial bones. In addition, double 
heterozygotes for Twist1 and Runx2 deletion show a partial rescue of the widened 
calvarial sutures seen in Runx2 heterozygous mice (Bialek et al., 2004). 
Runx2 is phosphorylated and can be activated by the mitogen-activated protein 
kinase (MAPK) pathway, stimulated either by extracellular matrix binding integrin 
on the cell surface or Fgf2. Parathyroid hormone/parathyroid hormone-related pep-
tide is also able to phosphorylate and activate Runx2 protein (Thirunavukkarasu et 
al., 1998; reviewed by Franceschi et al., 2003). All three Runx genes are also tran-
scriptionally controlled by retinoid/vitamin D nuclear receptors with positive regu-
latory effect on Runx1 and 3 but negative for Runx2 (Drissi et al., 2002). 
At least Osterix, a zinc finger containing transcription factor, has been shown to 
act downstream of Runx2 during osteoblast differentiation. In Osterix -/- mice, 
both the endochondral and intramembranous bone formation is absent but Runx2 
expression is normal and no tooth defects are present (Nakashima et al., 2002). 
Runx2 heterozygous mice have delayed tooth eruption and reduction of osteo-
clast recruitment to the jaws (Yoda et al., 2004). Rankl, a member of the Tnf fam-
ily, is produced by osteoblasts and acts as a differentiation and activation factor for 
osteoclasts (Yasuda et al., 1998). Rankl expression is severely diminished and os-
teoclastogenesis abolished in Runx2 -/- mice and by adding soluble Rankl protein, 
partial rescue of the osteoclastogenesis can be achieved (Enomoto et al., 2003). 
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Cleidocranial dysplasia syndrome 
Cleidocranial dysplasia is a rare bone dysplasia caused by mutations in Runx2 gene 
with autosomal dominant inheritance. The condition is characterized by general-
ized bone dysplasia including delayed ossification of calvarial sutures and fon-
tanelles, supernumerary and unerupted teeth, hypoplastic or missing clavicles and 
short stature (Gorlin, 2001). RUNX2 haploinsufficiency is the cause of CCD in 
humans and mice (Mundlos et al., 1997; Otto et al., 1997). Mutations in RUNX2
causing haploinsufficiency include chromosomal translocations, insertions, dele-
tions, nonsense, missense and frameshift mutations (Otto et al., 2002) (Fig. 9). It 
has been suggested that 20%-40% represent new mutations (Gorlin, 2001). 
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Fig. 9. Schematic representation of localization and type of mutations in RUNX2 causing 
CCD (based on review by Otto et al., 2002). RUNX2 gene is located on chromosome 6p21 
and contains eight exons. 
The general appearance of CCD patients is characterized by short stature, pro-
nounced frontal and parietal bossing, hypertelorism, hypoplastic maxilla and zy-
goma, broad nose at the base and narrow shoulders (Gorlin, 2001). The cranium is 
large but shows short biparietal bossing and the cranial base has a short sagittal 
diameter (Richardsson et al., 1994). In addition, the mandibular length is increased, 
maxilla is short vertically, paranasal sinuses and mastoids may be underdeveloped 
or absent and closure of the anterior fontanelle and sagittal and metopic sutures is 
delayed (Gorlin, 2001). Secondary centers of ossification may form in the sutures 
and give rise to Wormian bones, especially in lambdoid suture (Gorlin, 2001). 
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The clavicles are usually hypoplastic and the defect is more frequent at the ac-
romial end. In some cases the clavicle has a central gap where fibrous connective 
tissue has replaced the bone. The clavicles are absent unilaterally or bilaterally in 
about 10% of the patients (Gorlin et al., 2003). Also other bones of non intramem-
branous origin are affected in CCD patients, including pubic symphysis with de-
layed closure, cone-shaped thorax, lumbar spondylosis, short broad thumbs, short 
middle phalanges and metatarsals (Gorlin, 2001).  
CCD patients have several oral manifestations such as highly arched palate, de-
layed union at the mandibular symphysis, cleft palate, deficient ossification of the 
hyoid bone and poor development of premaxilla. The most characteristic features 
are, however, the dental anomalies including multiple supernumerary teeth but also 
multiple crown and root abnormalities, ectopic localization of teeth, and lack of 
eruption of permanent teeth. Some patients may even have a complete tertiary den-
tition (Jensen and Kreiborg, 1990). Based on the observation that epithelial rem-
nants were associated with extracted teeth of CCD patients it was suggested that 
the supernumerary teeth may have resulted from lack of resorption of dental lamina 
epithelium (Lukinmaa et al., 1995). It has also been reported that cellular cemen-
tum in the roots of CCD patients’ permanent teeth is absent and acellular cemen-
tum is partially hyperplastic (Jensen, 1990; Seow and Hertzberg, 1995; Lukinmaa 
et al., 1995). It has been proposed that insufficient Runx2 activity may affect the 
differentiation of both osteoblasts and osteoclasts thus leading to diminished bone 
resorption of bone surfaces and delayed resorption of the primary teeth and subse-
quent delayed eruption of permanent teeth (Kreiborg et al., 1999). 
Supernumerary teeth appear most often in the mandibular premolar and maxil-
lary incisor region and the average number of extra teeth is five (Gorlin, 2001). 
Jensen and Kreiborg carried out a thorough study of 20 patients and showed that 
the primary teeth and permanent tooth crowns were normal. Primary teeth did also 
erupt normally but the permanent teeth did not, except for the first molars and oc-
casionally other teeth too. Interestingly, they showed that during permanent tooth 
crown development the dental lamina was reactivated to form supernumerary teeth. 
Hence, supernumerary teeth are usually morphologically similar to their predeces-
sors (Jensen and Kreiborg, 1990).  
Several studies have tried to establish a correlation between the genotype and 
phenotype in CCD patients by mutational analysis of RUNX2 (Yoshida et al., 2002; 
Quack et al., 1999; Zhou et al., 1999). It has been shown that mutations affecting 
the runt domain and resulting in haploinsufficiency yields a classic CCD while 
mutations outside this domain may result in hypomorphic states with wide clinical 
variety ( Zhou et al., 1999). Accordingly, mutated protein associated with mild 
CCD, including isolated dental anomalies, have been shown to exhibit normal 
DNA binding and not causing haploinsufficiency but to be hypomorphic in nature, 
probably due to disturbance of Runx2 interaction with other modulators (Zhou et 
al., 1999). In addition, also a missense mutation in the very 3´ end of the coding 
region caused an isolated dental anomaly consisting of supernumerary teeth with 
no other CCD features (Quack et al., 1999). In this mutation the VWRPY motif 
that has been suggested to interact with the TLE transcriptional corepressor family 
is affected (Quack et al., 1999). A mutation in RUNX2 from a CCD patient has 
been described where RUNX2 protein failed to interact and respond to Smads 
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(Zhang et al., 1999). A correlation between short stature and supernumerary teeth 
has also been made and from the number of supernumerary teeth predictions of 
final height could be made, although the generality remains to be established (Yo-
shida et al., 2002). It has also been suggested that the intramembranous bone for-
mation is more sensitive to RUNX2 gene-dosage than endochondral bone formation 
thus explaining why almost always some cleidocranial abnormality is present but 
not always skeletal abnormalities (Yoshida et al., 2002). Interestingly, the dental 
and skeletal abnormalities correlate but also isolated dental abnormalities can oc-
cur. This could reflect the different functional components of Runx2. It seems that 
Runx2 is developmentally differentally regulated in bone and tooth with different 
upstream regulators and downstream targets (James et al., 2006). 
 39
AIMS OF THE STUDY 
The aim of this study was to investigate the pathogenesis of CCD, in particular the 
functions of Runx2 and Bmps in tooth development. The specific aims were: 
1. to perform a thorough comparative analysis of the expression of Bmps2
through 7 during mouse tooth development in order to elucidate possible 
functions
2. to examine in detail the tooth phenotype of Runx2 mutant mice 
3. to analyze the expression pattern of Runx2 during mouse tooth development 
as a basis for functional studies 
4. to identify the possible upstream regulators and downstream targets of 
Runx2 during tooth development in order to understand CCD pathogenesis 
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MATERIALS AND METHODS 
Materials and methods used in the thesis are listed in following three tables; Mouse 
strains, Probes, and Methods. A detailed description of each method can be found 
in the original publications.  
Table 1. Mouse strains used in articles I-IV 
Mouse strain Used in 
article
Described in article Purpose 
    
CBAT6T6 x 
NMRI 
I, II, III, 
IV
- Expression pattern analyzes of 
mRNA and proteins 
Runx2 null 
mutant mice 
II, III, IV Originally; Otto et al, 
1997. Maintenance; III. 
Analysis of phenotype and 
role in tooth development 
Msx1 null 
mutant mice 
III Satokata and Maas, 1994; 
Bei and Maas, 1998. 
Runx2 upstream regulation 
Lef1 null 
mutant mice 
III van Genderen et al., 1994 Runx2 upstream regulation 
Tabby null 
mutant mice 
III Pispa et al., 1999 Runx2 upstream regulation 
Nude mice III, IV Kratochwil et al., 1996 Kidney capsule transplantation 
of explants 
Table 2. Probes used for in situ hybridisation in articles I-IV 
Probe Description or reference Used in publication 
   
Activin ?A Erämaa et al., 1992 IV 
Ameloblastin Lee et al., 1996 III 
Bmp2 and Bmp4 Vainio et al., 1993 I, IV 
Bmp3, -5, -6, and -7 Åberg et al., 1997 (III) I, IV 
Pro?1(I) collagen Metsäranta et al., 1991 II, III 
Dan Dionne et al., 2001 IV 
Dspp D´Souza et al., 1997 II, III 
Dentin matrix protein-1 D´Souza et al., 1997 III 
Ectodin Åberg et al., 2004 (IV) IV 
Eda and Edar Laurikkala et al., 2001 IV 
Fgf3 and Fgf10 Kettunen et al., 2000 IV 
Fgf4 Jernvall et al., 1994 IV 
Fgfr1 Trokovic et al., 2003 IV 
Hairless Åberg et al., 2004 (IV) IV 
Hes1 and Hes5 Mustonen et al., 2002 IV 
Lef1 Travis et al., 1991 IV 
Lunatic Fringe Mustonen et al., 2002 IV 
Mmp2 Sahlberg et al., 1999 IV 
Msx1 and Msx2 Jowett et al., 1993 IV 
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Osteocalcin Ducy et al., 1997 III 
p21 Jernvall et al., 1998 IV 
Pax9 Neubuser et al., 1997 IV 
Runx1 and Runx3 Yamashiro et al., 2002 IV 
Runx2 D´Souza et al., 1999 II, IV 
Shh Vaahtokari et al., 1996 IV 
Sprouty1, -2, and -4 Zhang et al., 2001 IV 
Tgf?1 Vaahtokari et al., 1991 IV 
Timp1 and Timp3 Sahlberg et al., 1999 IV 
Twist Rice et al., 2000 IV 
Wnt5a, -10a, -10b, and -
11a 
Dassule and McMahon, 
1998; Sarkar and Sharpe, 
1999 
IV
Table 3. Methods used and described in articles I-IV 
Method Described in  Used in article 
   
Processing of tissues I I, II, III, IV 
Tissue culture and bead implantation assays II, III, IV II, III, IV 
Rescue experiments IV IV 
Kidney capsule implantation III, IV III, IV 
Genotyping by PCR II, IV II, III, IV 
Radioactive in situ hybridisation of sections I, II I, II, III, IV 
Whole mount in situ hybridisation II II, IV 
Immunohistochemistry IV IV 
RT-PCR II, III II, III 
Cell transfection and analysis of gene in-
duction 
IV IV 
3D reconstruction I I 
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RESULTS AND DISCUSSION 
Expression of Bmps during tooth development (I) 
We performed a careful comparative analysis of the expression of Bmp2, -3, -4, -5, 
-6, and -7 from the time of initiation of mouse tooth development to the stage of 
mineralization of the dentin and enamel matrices. Morphological details of the 
stages of tooth development which were analyzed is shown in Figs. 5 and 6 (pages 
25 and 29) and a summary of the expression patterns in Fig. 10 (page 45)(based on 
publication I, Figs. 3-5). 
Bmp4 expression was detected in the oral epithelium at the time of tooth initia-
tion at E10 and subsequently, at E11-12, expression was detected transiently both 
in the epithelium and mesenchyme. However, before the dental placode is formed, 
it shifted completely to the mesenchyme. Bmp2 transcripts were detected in those 
areas of the dental lamina where it started to form a bud, including the dental pla-
code. Bmp7 transcripts were detected throughout the oral epithelium at the time of 
the formation of the dental lamina, at E10 (data not shown). 
 At early bud stage Bmp2 was detected throughout the bud but it became subse-
quently concentrated at the tip of the bud during bud stage. Weak expression of 
Bmp3 transcripts was first detected at early bud stage and localized at the lingual 
aspect of the dental lamina in the area of tooth bud. Bmp4 was detected in the con-
densed dental mesenchyme around the epithelial bud with somewhat more intense 
expression at the buccal side of the tooth. Weak expression of Bmp6 was first de-
tected at the early bud stage in the condensed mesenchyme surrounding the bud. 
Bmp7 transcripts became localized at early bud stage in the tip of the bud. The 
expression pattern resembled that of Bmp2 except that the expression was present 
also in the oral epithelium.  
 The expression of Bmp2 was intense at E14 and restricted to the epithelial 
enamel knot. As the enamel knot started to disappear during late cap stage (E15), 
Bmp2 expression spread to the neighbouring inner dental epithelium. At cap stage 
expression of Bmp3 was seen in the dental papilla mesenchyme underlying the 
enamel knot. Bmp3 expression was also seen in the dental follicle mesenchyme and 
intense expression was seen in lingual side of the outer dental epithelium. A high 
level of Bmp4 expression continued in the dental papilla mesenchyme, and it reap-
peared in the epithelium in the distal part of the enamel knot. Bmp6 was expressed 
in the dental mesenchyme underlying the lingual epithelial cervical loop. Expres-
sion of Bmp7 was localized to the enamel knot extending somewhat outside the 
area. When the enamel knot started to disappear (E15), the expression of Bmp7
continued in the inner dental epithelium.  
 43
 At the early bell stage, Bmp2 expression had disappeared from the epithelium 
(E16) and had shifted to the central cells of the dental papilla mesenchyme (E17). 
Subsequently (E18), expression extended coronally in the dental papilla and be-
came prominent in the preodontoblasts. Expression of Bmp3 continued in the den-
tal follicle. The expression of Bmp4 disappeared from the dental epithelium with 
the removal of the enamel knot, and became intense in the cuspal area of the dental 
papilla including the preodontoblastic layer. The central cells of the dental papilla 
showed very weak or no expression. The expression of Bmp5 was seen for the first 
time in the differentiating preameloblasts (E18). The expression of Bmp7 continued 
throughout the inner enamel epithelium/preameloblasts (E18) except in its cervical 
parts. It shifted to the preodontoblasts as they started to secrete predentin matrix 
(E19).
 Expression of Bmp2 continued in the odontoblasts when predentine secretion 
began (P1). During the first postnatal days, transcripts disappeared from the most 
advanced odontoblasts in the cuspal areas, and Bmp2 expression was subsequently 
detected in functional ameloblasts. At P4, transcripts were seen mainly in the apical 
parts of the crown where differentiation continued. Some expression continued in 
the central cells of the dental papilla. Intense expression of Bmp3 continued in the 
dental follicle cells. Expression of Bmp4 was detected in the odontoblast and 
ameloblast cell layers. Expression in the odontoblasts decreased with advancing 
development whereas it persisted in the ameloblasts. Bmp5 expression continued 
intensely in the ameloblast cell lineage during all stages of their differentiation and 
matrix secretion. The expression pattern of Bmp7 was similar to that of Bmp2.
The function of Bmps in the regulation of tooth morphogenesis 
Bmps regulate most aspects of embryonic development and they are used repeat-
edly during the morphogenesis of various organs. The identification of signaling 
centres, i.e. enamel knots, in the developing tooth has greatly advanced the under-
standing of the interactions involved in tooth development. At the time of our ex-
pression pattern analysis there was very little functional evidence of Bmp involve-
ment in tooth development. It is obvious that the expression does not implicate 
function of any gene product, but the function of some of the Bmps in tooth have 
been demonstrated after 1997. Our expression pattern analysis has later proven to 
be a valuable resource of information in these studies.  
Knockout studies showed that null mutants of Bmp2 and -4 are early embryonic 
lethal. Bmp7 knockout lacked a tooth phenotype, perhaps due to redundancy with 
Bmp2. In addition, a Cre-mediated deletion of the gene encoding Bmp receptor 1A 
in the surface epithelium and its derivativ causes arrest of tooth morphogenesis. 
The tooth buds, although significantly smaller, are formed but then regress (Andl et 
al., 2004). Furthermore, it has been shown that attenuation of Smad2 results in an 
advancement of tooth development wheras attenuation of Smad7 inhibits tooth 
development (Ito et al., 2001).  
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During the initiation of tooth development, epithelial signals induce mesenchymal 
factors that then reciprocally act on the dental epithelium to form the signaling 
center, also called dental placode. Bmp4 and Activin ?A have been proposed to be 
the key signals from the mesenchyme to induce the epithelial signaling center and 
subsequent budding of the tooth (Jernvall and Thesleff, 2000). Epithelial Bmp4 
induces the mesenchymal Bmp4 expression via Msx1 and this shift of expression 
from epithelium to mesenchyme (E11.5) coincides with the shift of the potential to 
instruct tooth development (Vainio et al., 1993; Mina and Kollar, 1987). Simulta-
neously, Msx1 expression becomes restricted to the tooth bud regions in the mes-
enchyme (Coburne and Sharpe, 2003). Bmp4 induces p21 in the dental placode. 
p21 is associated with the stop of cell proliferation and has been shown to be ex-
pressed in several signaling centers (Jernvall et al., 1998). 
Later, during the cap stage, Bmp4 is expressed in the enamel knot as well as in 
the mesenchymal dental papilla. Bmp7 is coexpressed with Bmp2 during early 
tooth development and also expressed in all signaling centers, if not as specifically 
as Bmp2. Better understanding of Bmp functions has been gathered from knockouts 
of other genes involved in tooth development. A common feature of the knockout 
of transcription factors Msx1 and Pax9 is that expression of Bmp4 is missing from 
the dental mesenchyme. In all of these mutants, the formation of the enamel knot 
has been impaired which suggests that it is a prerequisite for the tooth bud to de-
velop into cap stage. This indicates that Bmp4 is a good candidate for a mesen-
chymal signal inducing the transition from bud to cap. Accordingly, in the Msx1
knockout, tooth development is arrested at bud stage but can be rescued by adding 
exogenous Bmp4 protein. Bmp signaling requires also the receptors in the target 
tissues to be functional, expression of Bmps as such does not indicate if it is func-
tional or redundant. Recently, presence of BmprIA and –II has been shown by im-
munostaining at bud stage in the epithelium and of BmprIB and -II in the mesen-
chyme (Nadiri et al., 2006). At cap stage, BmprIB but not -II was shown to be pre-
sent in the epithelium and at later cap stage both Bmpr1A and –II were present in 
the enamel knot, simultaneously with Bmp4 (Nadiri et al., 2006). These results 
coincide with the Bmp expression and suggesting that there is functional signaling 
possible.
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Fig. 10. Summary of the expression of Bmp2-7 during tooth development. Dental 
epithelium is shown in yellow. Gene expressions in the epithelium are shown in red 
and in the mesenchyme in green.
Later function of BMPs in the differentiation of odontoblasts and 
ameloblasts and in dentin and enamel deposition 
The dentin-forming odontoblasts and the enamel-forming ameloblast differentiate 
during bell stage at the interface between the dental epithelium and mesenchyme, 
and there is abundant experimental evidence indicating that the differentiation of 
these cells is regulated by interactions between the two cell lineages (Thesleff and 
Hurmerinta, 1981; Ruch et al., 1995). The expression of Bmp2, -4, and -7 showed 
apparent associations with the differentiation of odontoblasts and ameloblasts. In 
line with this, in vitro experiment have shown that Bmp2, -4, and -6 can induce 
polarization of preodontoblasts and stimulate dentin matrix secretion (Begue-Kirn 
et al., 1994; Ruch et al., 1998). In addition, inductive roles of Bmps on odonto-
blasts differentiations have also been demonstrated in numerous transplantation 
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studies in which implantation of Bmps into the dental pulp induced de novo denti-
nogenesis (Lianja et al., 1993; Nakashima, 1994; Nakashima and Akamine, 2005). 
As in odontoblast differentiation, ameloblast cytodifferentation has also been 
shown to be induced by Tgf?1 and Bmp2 (Begue-Kirn et al., 1992, 1994). Our 
localization of Bmp transcripts show that they are present at the right time and loca-
tion to act as mesenchymal signals on the differentiation of the inner enamel epi-
thelium into ameloblasts. In addition, subsequent studies from our laboratory has 
shown that of the Bmps expressed by odontoblasts Bmp4 is most important (Wang 
et al., 2004). The Bmp receptors are also present in the ameloblasts and odonto-
blasts indicating that functional signaling is possible (Nadir et al., 2006). 
The Bmp3 expression pattern suggests that it may be involved in the formation 
of cementum. However, as the dental follicle regulates bone formation around the 
developing tooth, it is possible that Bmp3 is involved in the regulation of osteoblast 
functions in the alveolar bone. Recently, Bmp3 has been shown to have effects 
opposite to Bmp2, -4 and Activin and to function as a Bmp inhibitor (reviewed by 
Li and Cao, 2006). Indeed, the Bmp3 expression at the lingual side of the bud and 
cap stage tooth could indicate an inhibitory function in successive tooth formation. 
Bmp5 apparently has no function in the regulation of morphogenesis, but is rather 
associated with cell differentiation. The function of the transient expression of 
Bmp6 at bud and cap stage remains unclear and we could not detect it in later 
stages.
It has become more and more evident that signals of the Tgf? family must be 
tightly regulated, and therefore finely tuned antagonistic effects between Tgf? su-
perfamily signals and their inhibitors are critical for normal tooth development. 
Mice with deleted Ectodin function (Ectodin is a Bmp inhibitor) have severe cusp 
patterning defects which show the importance of the correct ratio between activa-
tors and inhibitors (Laurikkala et al., 2003; Kassai et al., 2005). In addition, Fol-
listatin regulates enamel patterning in mouse incisors by asymmetrically inhibiting 
Bmp signaling and thus ameloblast differentiation (Wang et al., 2004). 
In conclusion, our findings are in line with the concept that Bmps have several 
different functions during tooth development. It is conceivable that they signal 
between the epithelial and mesenchymal tissues during initiation and morphogene-
sis of tooth development, as well as during the differentiation of odontoblasts and 
ameloblasts. Furthermore, they are also part of the signaling networks whereby the 
enamel knot regulates the patterning of tooth cusps. In addition, they are involved 
in the regulation of the deposition of the matrices of the dental hard tissues. 
The role of Runx2 during tooth development (II, III, IV) 
Runx2 expression during tooth development (II) 
In situ hybridisation analysis did not reveal any Runx2 expression in mouse cranio-
facial tissue at E11. At E12, Runx2 expression became evident in areas of future 
osteogenesis. In addition, Runx2 expression was detected also in the mesenchyme 
underlying the dental epithelium, although the signal was very weak as compared 
to the expression in bone (II Fig. 2A-B). At E13, the Runx2 expression continued 
in the preosteogenic mesenchyme and spread also to the nasal capsule. Intense 
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expression was observed in the mesenchyme surrounding the tip of the epithelial 
tooth bud at E13 (II Fig. 2C-D). At the cap stage (E14), high level of expression 
was evident in the dental papilla and follicle as well as in the osteogenic zones, 
clearly demarcating these regions from the surrounding tissues (II Fig. 2E-F). By 
E16, the early bell stage, Runx2 expression was markedly downregulated in cuspal 
regions of the dental papilla mesenchyme (II Fig. 2G-H). At the late bell stage 
(E18), Runx2 mRNA was downregulated throughout the dental papilla, however, 
intense expression remained in the dental follicle and in osteoblasts within the al-
veolar bone (II Fig. 2I-J). At the newborn stage (NB) and at 4 dpn Runx2 expres-
sion was intense in all osteoblasts and in the dental follicle that will give rise to 
cementoblasts and periodontal ligament (II Fig. 3A-B). Newly differentiated odon-
toblasts and dental pulp cells near the cervical loop showed weak levels of Runx2
expression while mature odontoblasts were negative (II Fig. 3B). At 7dpn, intense 
expression of Runx2 remained in the dental follicle. Unlike secretory ameloblasts 
that appeared negative, maturation stage ameloblasts appeared strongly positive for 
Runx2 (II Fig. 3E-F). In addition, we showed that Runx2 expression is downregu-
lated in differentiated odontoblasts prior to the expression of dentin matrix genes 
(II Fig. 3G-H). 
 The pattern of Runx2 mRNA in the dental mesenchyme correlates with key 
developmental events. The inductive potential of the odontogenic epithelium shifts 
to the mesenchyme at E12, when Runx2 expression also begins in the presumptive 
tooth mesenchyme (Jernvall and Thesleff, 2000). Hence, the onset of the expres-
sion in the dental papilla mesenchyme follows its acquisition of the odontogenic 
potential. Because Runx2 expression is downregulated at the late cap stage, it 
seems that it is not involved in the formation of secondary enamel knots and subse-
quent cuspal development. However, we do not know the Runx2 protein half life 
and can not predict when the protein activity is lost after the downregulation of the 
mRNA. Accordingly, we can not be certain that Runx2 is not involved in odonto-
blast differentation based on the downregulation of the mRNA. 
In addition, the developmental profiles of Runx2 expression in odontoblasts and 
osteoblasts appear different suggesting that the gene may be differentially regulated 
in these cells and that Runx2 may not have a similar function as differentation in-
ducer in odontoblasts as it does in osteoblasts. 
 Furthermore, expression pattern analysis of three Runx2 isoforms was per-
formed in newborn mouse incisors which showed that all isoforms were expressed 
in both teeth and bone although with different relative levels (Chen et al., 2002). 
Although several different isoforms exists, it is not known if they have different 
specific functions or if they are redundant.  
The dental phenotype of Runx2 null mutant mice (II-III)
To elucidate Runx2 function during tooth development, we examined the pheno-
type of teeth in Runx2 null mutant mice. These mice die at birth and we started by a 
histological analysis of Runx2 -/- jaws. Frontal sections of the molar region of 
Runx2 -/- embryos and their wild-type littermates were examined at developmental 
stages of E12, E13, E14, E16, and E18 (E12-13: data not shown, E14-E18: II Fig. 4 
and III Fig. 1).  
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At E12, the wild-type and Runx2 -/- tooth germs were morphologically similar and 
the first difference was observed during the early bud stage, when molar tooth buds 
of Runx2 -/- were slightly delayed in development (data not shown). By cap stage 
(E14), the developmental arrest was remarkable in both upper and lower molars 
(III Fig. 1B-C). Although the dental mesenchymal condensate appeared normal in 
Runx2 -/- molars, the enamel knot was not visible as a morphologically distinct 
entity within the ectodermal compartment. A characteristic feature of the upper 
molar epithelium at E14 was the presence of an extra budding at the palatal side of 
the bud (III Fig. 1C). The morphogenesis of Runx2 -/- molars did not proceed dur-
ing subsequent embryonic development. In addition, absence of Runx2 affected 
mandibular molars more severely than maxillary molars (II Fig. 4C-D, III Fig. 1E). 
At E18, the lower molar tooth bud of Runx2 -/- could not be distinguished from the 
highly proliferative dental lamina in contrast to the upper molar where the arrest at 
bud stage still was visible (III Fig. 1H-I). 
 We had predicted that Runx2 -/- mice would have numerous supernumerary 
teeth because of the phenotype seen in CCD patients. To our surprise, no extra 
teeth were found but instead, a complete arrest at bud stage was evident. Mice ex-
hibit only one dentition which has been suggested to represent the primary denti-
tion in humans (Kreiborg et al., 1999) and the palatal bud observed in the Runx2 -/- 
upper molars could represent the site of formation of succesional dentition. In con-
clusion, it appears that Runx2 is required for the tooth morphogenesis in the transi-
tion from bud to cap stage, and that it inhibits extra epithelial bud protrusion and 
subsequent formation of successional dentition. Support for the latter has come 
form a later study of Shh involvement in the Runx2 signaling (Wang et al., 2005). 
Regulation of Runx2 expression in embryonic mesenchyme (II, IV) 
There is evidence that bone formation in the embryonic facial processes is depend-
ent on signals from the epithelium (Hall, 1978). By culturing E11 mandibular arch 
mesenchyme with or without the presence of epithelium and analyzing Runx2 ex-
pression, we could conclude that epithelium was not needed for the induction or 
maintenance of Runx2 expression in mandibular mesenchyme (II Fig. 5A-C). 
However, similar cultures of tooth mesenchyme, with or without epithelium 
showed that epithelium is needed for the onset and maintenance of Runx2 (II Fig. 
5D-N). When tooth mesenchyme from E11-14 teeth was cultured alone, no expres-
sion of Runx2 was seen (II Fig. 5J-K). When the mesenchyme was recombined 
with epithelium, Runx2 expression was induced in the mesenchyme adjacent to the 
epithelium from E13 onwards (II Fig. 5G-I). The conclusion from these cultures 
was that dental epithelium is capable of stimulating Runx2 in dental mesenchyme 
during the bud stage. 
 Because Fgfs and Bmps are known epithelial signals in the regulation of tooth 
morphogenesis, we examined whether these signals could be responsible for the 
epithelial induction and maintenance of Runx2 in the mesenchyme. In addition, 
Bmps were shown to induce Runx2 in bone development (reviewed by Otto et al., 
2003). Hence, it would be conceivable that Bmps are involved in the regulation of 
Runx2 during tooth development. However, this was not the case. We did bead 
implantation experiments on E11-E14 lower molar mesenchymes using Bmp2, -4 
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and -7 proteins and analyzed the explants for Runx2 expression by whole mount in 
situ hybridisation. Our results showed, surprisingly, that Bmp2, -4, and -7 could 
not induce Runx2 expression in the tooth mesenchyme at any stage between E11-
14 (II Fig. 6A-G). However, similar bead implantation experiments using Fgf8 
protein on E11-12 dental mesenchyme and Fgf4 protein on E13-14 explants 
showed that Fgf4 induced the expression of Runx2 in isolated dental mesenchyme 
from E13 onwards (II Fig. 7A-H). 
 Our results show that dental epithelium regulates mesenchymal Runx2 expres-
sion and that these effects can be mimicked by the FGFs but not by the BMPs. We 
conclude from these results that Runx2 regulates the expression of molecules in the 
mesenchyme that act reciprocally on the epithelium to control its morphogenesis. 
In addition, the role of Runx2 in tooth development may be distinct from its role in 
bone development. Indeed, a recent study has shown that Runx2 has different 
downstream targets in the bone and tooth (James et al., 2006). 
Tooth development is arrested in several mouse mutants and to gain more insights 
into the upstream regulation of Runx2, we analyzed its expression in the arrested 
tooth buds of mouse embryos lacking the function of Msx1, Lef1, and Ectodys-
plasin (Eda) (IV Fig. 1B-G). 
In situ hybridisation analysis of serial sections of E14 Msx -/- heads indicated 
that Runx2 expression was downregulated in the mesenchyme around the tooth 
bud, although intense expression was apparent in the area of forming mandibular 
bone. This finding indicates that Msx1 is needed for the expression of Runx2 in the 
dental but not osteogenic mesenchyme (IV Fig. 1E). 
 In Lef1 null mutant teeth, the defect has been localized to the dental epithelium 
where Lef1 is required for the expression of Fgf4 and for subsequent induction of 
mesenchymal Fgf signals (Kratochwil et al., 1996; 2002). However, Runx2 expres-
sion was apparently normal in the dental and osteogenic mesenchyme of Lef1 mu-
tant embryos, indicating that Lef1 is not needed for Runx2 expression. However, 
we cannot rule out the possibility that Wnt signals could regulate Runx2 via other 
transcription factors (IV Fig. 1F). 
Runx2 was intensely expressed throughout dental and osteogenic mesenchyme 
in the E14 Eda null mutants. Since the defect in Eda mutants is in the enamel knot, 
Runx2 could not be a direct target, but our results indicate that Runx2 expression is 
not even secondarily affected by Eda-Edar signaling (IV Fig. 1G). 
 Search for downstream targets of Runx2 (IV) 
To position Runx2 in the known signaling pathways regulating the bud to cap stage 
transition during tooth development, we examined the expression of potential 
downstream target genes of Runx2, by using in situ hybridisation. We compared 
E14 Runx2 -/- tooth germs with both E13 (bud) and E14 (cap) wild-type teeth, 
since remarkable changes take place in gene expressions between bud and cap 
stages and Runx2 -/- teeth are arrested between them. 
 The expression patterns of altogether 37 genes were compared between the 
teeth of Runx2 -/- and their wild-type or heterozygous littermates. We described the 
patterns of the following genes in Runx2 -/- and wild-type teeth: Fgf3, Fgf4, Fgf10, 
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Fgfr1, Sprouty1, -2, and -4, Bmp2 and -4, Lef1, Tgf?1, Msx1 and -2 (data not 
shown), Shh, Activin ?A, p21, Pax9, Edar, Twist (data not shown), Wnt5a, -10b, 
Runx1, Runx3, and Tenascin. In addition, we analyzed the expression of the follow-
ing genes and proteins but no apparent differences between the wild-type and 
Runx2 -/- was found: The Notch pathway genes Hes1, Hes5, and L-fng; Bmp in-
hibitors Dan and Ectodin, Wnt10a, Wnt11a, Eda; the matrix metalloproteinase 
Mmp2; and the Mmp inhibitors Timp2 and Timp3, hairless, and the basement 
membrane molecule laminin1 (data not shown).  
 Most genes in the mesenchymal condensate were normally expressed in Runx2 
-/- teeth. We did not detect any significant changes in the expression of Msx1,
Bmp4, Pax9, Lef1, Tgf?1, Wnt5a, and Tenascin in Runx2 -/- molars (IV Fig. 2A-T). 
However, Activin ?A expression was markedly reduced in both upper and lower 
molars of Runx2 mutants, especially in the mesenchymal cells immediately under-
neath the epithelial bud (IV Fig. 2R). This suggests that Activin ?A may be down-
stream of Runx2 in this restricted cell population. 
 Fgfs act as both epithelial and mesenchymal signals and regulate tooth devel-
opment at all stages and we have shown that Runx2 is a target of Fgf signaling in 
the tooth. Therefore, we analyzed the expression patterns of several genes in the 
Fgf signaling pathway in Runx2 -/- teeth. Since Fgf3 and Fgf10 are coexpressed 
with Runx2 in the wild-type dental mesenchyme, they were candidates to be direct 
downstream targets. Interestingly, Fgf3 expression was virtually absent from the 
Runx2 mutant tooth germs and only occasionally was faint signal seen in mutant 
upper molar (IV Fig. 3C). No significant difference was found in expression pat-
terns between Runx2 -/- and wild-type teeth of following genes: Fgf10, Fgfr1, and 
Sprouty1 (IV Fig. 3D-L). However, Sprouty2 and -4 were downregulated in the 
epithelium of Runx2 -/- teeth (IV Fig. 3M-R). In conclusion, Fgf3 is a possible 
target gene of Runx2. The specific reduction in the expression of Sprouty2 and 
Sprouty4 in Runx2 -/- dental epithelium suggest that Fgf signaling was inhibited 
there and that Fgf3 is a reciprocal signal affecting dental epithelium. In line with 
this, we showed that overexpression of Runx2 can induce Fgf3 expression in Runx2
-/- calvarial cells. This result further indicates that Fgf3 may be a target of Runx2 
in dental mesenchyme (IV Fig. 4A-B).  
 Previous work has shown that the expression of Fgf3 in the dental mesenchyme 
is controlled by dental epithelium and that the epithelial effect can be mimicked by 
epithelially expressed Fgfs (Kettunen et al., 2000); Bei and Maas, 1998). In line 
with this we showed that Fgf4 can induce Fgf3 in the dental mesenchyme at E13 
and E14 but failed to induce Fgf3 in the Runx2 -/- dental mesenchyme (IV Fig. 7A-
F). In addition, Fgf4 could induce Tgf?1 and Activin ?A in Runx2 -/- molars (IV 
Fig. 7G-O). This result showed that Runx2 mutant mesenchyme was competent to 
respond to Fgf signals and therefore the lack of Fgf receptors or other mediators of 
Fgf signals do not explain the lack of Fgf3 induction by Fgf4. Thus, Runx2 may 
directly regulate Fgf3 expression in the dental mesenchyme. Furthermore, we 
showed that Runx2 is expressed in the dental mesenchyme, regulated by epithelial 
Fgf signaling, and regulating Fgf3 expression in the dental mesenchyme indicating 
that Fgf3 may be a direct target gene of Runx2. It has also been shown that Fgf3 is 
missing in Msx1 -/- teeth and that its induction by Fgfs requires Msx1 (Bei and 
Maas, 1998). These findings together with the downregulation of Runx2 in Msx1 -/- 
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teeth suggest that Runx2 can be placed between Msx1 and Fgf3 and that it is re-
sponsible for mediating Fgf signaling from the dental epithelium to the mesen-
chyme (Fig. 11).  
Although the enamel knot is morphologically discernible only at cap stage, its 
induction takes place already at the late bud stage when many enamel knot marker 
genes are upregulated (Jernvall and Thesleff, 2000). Shh is one of the best charac-
terized enamel knot marker genes and is required for normal tooth morphogenesis. 
Shh expression was absent from the Runx -/- lower molar tooth buds, which sug-
gested that the enamel knots may not have formed in the Runx2 -/- teeth (IV Fig. 
5C). However, the analysis of the expression of other enamel knot marker genes 
indicated that a partially functional enamel knot actually starts to form in the mu-
tants. The genes analyzed included Wnt10b, Lef1, Fgf4, Bmp2, Edar, Msx2 and p21
(IV Fig. 5D-U). Surprisingly, most genes were expressed in the tips of mutant up-
per molar buds with similar intensities to those in the fully developed enamel knots 
of cap stage wild-types molars. Shh was weakly expressed in the upper molars of 
Runx2 -/-. However, in the lower molars of Runx2 mutant embryos, the enamel 
knot markers were either absent or reduced with the exception of Wnt10b, Lef1,
and Msx2, which were expressed with similar intensity as in wild-type molars (IV 
Fig. 5D-I, data not shown). These observations indicated that the enamel knots start 
to form in Runx2 -/- tooth buds and that there are differences between the upper 
and lower molar. Enamel knot signaling is believed to regulate the growth of the 
cervical loops either directly or indirectly via mesenchyme. Despite the expression 
of many enamel knot marker genes, the cervical loops did not form in either lower 
or upper Runx -/- molars which could be due to lack of Shh signaling in both upper 
and lower mutant molar. However, when Shh function was conditionally deleted in 
developing teeth (Dassule et al., 2000), cervical loop formation was only partly 
inhibited, which suggest that lack off Shh signaling can not be fully responsible for 
the arrest of Runx2 mutant teeth at bud stage. 
FGF
Msx1
Runx2
Fgf3
?
SHH
Wnt
Lef1
Fig. 11. Schematic representation of the genetic pathway involving Runx2 during 
bud to cap transition in tooth development.
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Attempts to rescue Runx2 mutants tooth development (III, IV) 
We performed tissue recombinations where dental epithelium and mesenchyme 
from wild-type and Runx2 -/- mandibular E13 molars were recombined in different 
combinations and cultured for 6-8 days. When Runx2 -/- mesenchyme was recom-
bined with wild-type epithelium, no obvious development occurred. When Runx2 -
/- epithelium was recombined with wild-type mesenchyme, normal and bell-staged 
molar morphology was seen. Hence, the primary defect in the Runx2 -/- tooth or-
gans resides in the dental mesenchyme and cannot be rescued by wild-type epithe-
lium. 
 Furthermore, we cultured Runx2 -/- molar organs under the kidney capsule of 
nude mice to examine if their development would be rescued under long term cul-
ture in vivo. However, only cyst-like structures formed and no teeth were observed. 
A wild-type tooth cultured for the same time formed a well-mineralized late bell 
stage tooth with surrounding alveolar bone. 
 We also tried to rescue the Shh expression in the enamel knot by adding exoge-
nous Fgf but no rescue was observed. Hence, our results indicate that lack of Fgf3 
in the Runx2 mutant teeth is not the only reason for the downregulation of Shh 
expression in the enamel knot. There may be other mesenchymal signal molecules 
that regulate Shh expression in the enamel knot. 
 Since Fgf3, Activin ?A, and Shh were all downregulated in Runx2 mutant teeth, 
we attempted to rescue the morphology by culturing them in the presence of the 
recombinant proteins Fgf4, Fgf10, Activin ?A and Shh. None of the signal mole-
cules rescued the morphogenesis of Runx2 mutant molars, either when introduced 
alone or in various combinations. 
 In conclusion, we observed that Runx2 has a dual role in tooth development: it 
is necessary for the bud stage tooth to proceed to cap stage but it is also needed to 
prevent extra budding from the epithelium. 
Runx2 and CCD  
The apparent difference between Runx2 heterozygote mouse and CCD human syn-
drome is the lack of supernumerary teeth in mice which is likely due to the lack of 
secondary dentition in mice. A correlation of genotype and phenotype have been 
observed in CCD patients. If a mutation in the runt domain takes place, which is 
necessary for DNA binding, a classical CCD occurs with a wide variety of affected 
structures (Zhou et al., 1999). However if the mutation occurs in the WVRPY -
3´end, which is the binding site for the TLE coreceptor, a CCD phenotype with 
only supernumerary teeth has been reported (Quack et al., 1999). This could be a 
coincidence but it fits well with the idea that Runx2 is needed to repress the bud-
ding of the dental lamina and to inhibit formation of the successional teeth. Other 
studies have concluded that there is no correlation between the phenotype and 
genotype but that could be due to small number of patients and perhaps that no 
mutations were observed in the TLE binding site (Otto et al., 2002). Another corre-
lation that has been observed is the height of CCD patients (SD) and the number of 
supernumerary teeth which is more difficult to explain (Yoshida et al., 2002). De-
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tailed study of mutations of Runx2 in CCD patients would be needed to detect fur-
ther genotype/phenotype correlation regarding supernumerary teeth. A recent study 
showed that activation of Wnt signaling leads to multiple extra teeth which sug-
gests that the repressor function of Runx2 could be downstream of Wnt (Järvinen 
et al., 2006). It has also been shown that Wnt acts through ?-catenin to interact with 
Runx2 and Smad which integrates Smad and Wnt pathways in interaction with 
Runx2 (Gaur et al., 2005). Furthermore, it is also evident that Bmp regulate Runx2
in bone tissues and Fgf in tooth development (James et al., 2006). This could indi-
cate that Bmp and Wnt regulate the repression function of Runx2 on the extra bud-
ding and successor tooth formation and that Fgf may regulate the activition of 
Runx2 that promote tooth development. 
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CONCLUDING REMARKS 
The understanding of molecular mechanisms controlling tooth development has 
greatly advanced during the last years. The developing tooth has proven to be a 
powerful model for studying the sequential signaling events involved in organo-
genesis in general. Our expression analysis of six different Bmps indicated that 
Bmp signals are produced by both mesenchyme and epithelium and are important 
reciprocal regulators of tooth development. The present study also showed that 
Runx2 is a transcription factor that is absolutely required for tooth development. In 
Runx2 null mutant mice tooth development is arrested at bud stage, and our analy-
sis of Runx2 function gained us further information about signaling pathways in-
volved in tooth development. We have demonstrated that Runx2 is an essential 
transcription factor mediating Fgf signaling and epithelial-mesenchymal interac-
tions in developing teeth during the transition from bud to cap stage. In addition, 
we show that Runx2 is required for the upregulation of Fgf3 gene expression. Our 
results also indicate that Runx2 regulates additional mesenchymal signals which 
are required for continued morphogenesis of teeth. 
 The finding that mutations in Runx2 cause in human and mice CCD, where 
bones as well as teeth are affected, provided an excellent opportunity to examine 
and compare the functions of one transcription factor in two different organs. Our 
studies suggested that Runx2 is differentially regulated in dental and bone mesen-
chyme. Interestingly, recent work has shown that Runx2 acts on different target 
genes and affects different signaling pathways in bones and teeth (James et al., 
2006). In addition, in vitro experiments, in the same study, determined that Runx2 
is part of the Fgf and Bmp signaling pathways in tooth and bone development, 
respectively. Hence, the available evidence suggests that Runx2 has a specific di-
rect function on tooth formation, which is not secondary to its effect on bone. 
In Runx2 null mutants, tooth development is arrested at bud stage, similarly as 
in Msx1, Pax9 and Lef1 mutants. However, unlike the other mouse mutants, the 
lower molars in Runx2 mutants were more severely affected than upper molars. In 
addition, in the upper molars of Runx2 mutants extra buddings occurred at the pala-
tal side of the tooth bud. Although mice do not develop a secondary dentition, these 
buds provided clues for the pathogenesis of CCD syndrome which is caused by 
RUNX2 haploinsufficiency and characterized by multiple supernumerary teeth. We 
suggested that these extra buds occurred at sites where the formation of the secon-
dary teeth is normally prevented in mice and that Runx2 acts as an inhibitor of 
successional tooth formation by preventing advancing development of the buds.  
We also showed that several genes expressed in the enamel knot were down-
regulated or missing in the Runx2 -/- lower molar but normal in the upper molar. In 
particular, Shh was absent in the lower molars, and very faintly expressed in the 
upper molars. In a subsequent study in our laboratory on Shh involvement in 
Runx2 signaling, it was shown that Shh as well as its mediators Ptc1, Ptc2, and 
Gli1 were downregulated in the lower molars of Runx2 null mutant whereas active 
Shh signaling was present in the extra buds of upper molars of Runx2 null mutants 
as well as of Runx2 mutant heterozygotes (Wang et al., 2005). This linked Shh
expression in the enamel knot with the onset of successional tooth formation. 
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It was shown recently that continuous tooth generation in mouse could be induced 
by activated Wnt/beta-catenin signaling, and it was suggested that this unlocked the 
capacity for tooth renewal that was lost in rodents more than 60 millions of years 
ago (Järvinen et al., 2006). Interestingly, these supernumerary teeth formed succes-
sionally from enamel knots expressing known markers including Shh. It was sug-
gested that the mechanism of continuous tooth generation involved the iterative 
formation of ectopic enamel knot signaling centers where enamel knot activation 
and lateral inhibition is the underlying key mechanism. The results from my studies 
are in line with this suggestion and it is tempting to speculate that the formation of 
the supernumerary teeth in cleidocranial dysplasia as a result of Runx2 haploinsuf-
ficieny results from modulation of the lateral inhibition mechanism that regulates 
enamel knot activation. The exact function of Runx2 in this process remains to be 
demonstrated. Runx2 was recently linked to Wnt signaling by the demonstration 
that Dkk1, a secreted Wnt antagonist, is a target of Runx2 in dental mesenchyme 
(James et al., 2006), and the work in this thesis work linked Runx2 to Fgf signal-
ing. Since Runx2 influences the expression of numerous genes in dental mesen-
chyme as shown by microarray analysis (James et al., 2006), it is possible that its 
role in the inhibition of successional tooth formation involves the modulation of 
several signaling pathways. Further studies are needed for more detailed dissection 
of the molecular basis for the pathogenesis of CCD. 
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